{"gene":"NCAM1","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1987,"finding":"NCAM is a member of the immunoglobulin superfamily with five contiguous Ig-like domains in its extracellular region. Three major polypeptide isoforms (120, 140, 180 kDa) share an identical extracellular region but differ in their membrane-associated and cytoplasmic domains through alternative RNA splicing. Homophilic binding is mediated by interactions among the Ig-like domains, and regulation is achieved not by changes in binding-site sequence but by cell surface modulation events (PSA content, prevalence, mobility) and alternative splicing that alter isoform-specific cytoplasmic interactions.","method":"cDNA cloning, amino acid sequencing of CNBr/proteolytic fragments, Northern blot","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — foundational structural paper with complete sequence determination and multiple orthogonal methods; >1000 citations","pmids":["3576199"],"is_preprint":false},{"year":1987,"finding":"A muscle-specific sequence domain (MSD1) of 37 amino acids is present in the extracellular region of the 5.2 and 4.3 kb NCAM isoforms expressed during myotube formation but absent from transmembrane isoforms in myoblasts and from brain NCAM, demonstrating tissue-specific alternative splicing within the extracellular domain.","method":"cDNA cloning, Northern blot, sequencing","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing of multiple cDNA isoforms with tissue-expression validation; >200 citations","pmids":["2887295"],"is_preprint":false},{"year":1988,"finding":"A secreted isoform of NCAM is generated by alternative splicing that inserts a novel exon into the extracellular domain, introducing an in-frame stop codon; stable transfectants expressing this isoform accumulate it intracellularly and secrete it into the medium, contrasting with GPI-anchored NCAM that is expressed at the cell surface.","method":"cDNA cloning, genomic analysis, stable transfection, immunoprecipitation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — reconstituted secretion in transfectants with molecular characterization; >200 citations","pmids":["3203385"],"is_preprint":false},{"year":1988,"finding":"NCAM regulates membrane-membrane contact required for diverse intercellular events. When NCAM carries low polysialic acid (PSA), adhesion is increased and contact-dependent signaling is triggered; when PSA content is high, the large excluded volume of PSA sterically inhibits membrane apposition and cell-cell interactions.","method":"Cell adhesion assays, enzymatic PSA removal, antibody blocking","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — multiple functional assays establishing PSA-mediated steric hindrance mechanism; >750 citations","pmids":["3281256"],"is_preprint":false},{"year":1990,"finding":"Mouse myoblasts transfected to constitutively express the human muscle-specific 125 kDa GPI-linked NCAM isoform fuse more readily to form myotubes than controls, demonstrating that NCAM promotes myoblast fusion and that the isoform switch (transmembrane to GPI-linked) may promote this function.","method":"Stable transfection of myoblasts, fusion assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function transfection with specific isoform and quantitative fusion readout; >100 citations","pmids":["2179732"],"is_preprint":false},{"year":1993,"finding":"The fourth Ig-like domain of NCAM contains a carbohydrate recognition domain (with sequence homology to C-type lectins) that mediates binding to oligomannosidic glycans on L1, forming a heterophilic cis-complex. A peptide from this domain disrupts L1-NCAM association and inhibits neurite outgrowth, demonstrating that carbohydrate-mediated cis-association between L1 and NCAM modulates their functional properties.","method":"Co-immunoprecipitation, carbohydrate inhibition assays, recombinant domain binding, peptide inhibition, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (co-IP, recombinant fragments, peptides, functional neurite assay); >190 citations","pmids":["8509458"],"is_preprint":false},{"year":1993,"finding":"Expression of the transmembrane NCAM-B isoform (but not GPI-linked NCAM-C) in NCAM-negative rat glioma cells induces down-regulation of 92-kDa gelatinase (MMP-9) and interstitial collagenase (MMP-1) secretion, indicating that transmembrane NCAM signaling regulates extracellular matrix metalloproteinase production.","method":"Transfection of NCAM isoforms into glioma cells, metalloproteinase zymography/activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — isoform-specific transfection with direct MMP activity measurement; replicated with two isoforms as controls","pmids":["8265575"],"is_preprint":false},{"year":1994,"finding":"The VASE exon (10 amino acids inserted into the fourth Ig domain) in NCAM receptors specifically inhibits NCAM-stimulated neurite outgrowth. Both the 140- and 180-kDa isoforms without VASE are functional receptors for neurite outgrowth; a VASE-containing peptide inhibits NCAM-dependent but not integrin-, N-cadherin-, or L1-dependent neurite outgrowth, suggesting that VASE prevents NCAM from engaging the FGF receptor.","method":"PC12 transfection with NCAM isoforms ± VASE, synthetic peptide inhibition, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean isoform-specific transfection, peptide specificity controls, multiple neuronal substrates tested","pmids":["8163558"],"is_preprint":false},{"year":1995,"finding":"Polysialylation of NCAM is catalyzed by a single enzyme, PST-1 (polysialyltransferase-1), as demonstrated by reconstitution of PSA synthesis on incompletely glycosylated NCAM variants in vitro using soluble recombinant enzyme. Terminal sialylation of the N-glycan core is sufficient to generate the PSA acceptor site.","method":"In vitro reconstitution with recombinant PST-1, incompletely glycosylated NCAM variants","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic reconstitution with defined substrates","pmids":["8805371"],"is_preprint":false},{"year":1995,"finding":"Molecular cloning of eukaryotic polysialyltransferase-1 (PST-1) and demonstration that expression of this single enzyme is sufficient to induce PSA synthesis on all NCAM-expressing cell lines in reconstitution experiments, establishing that polycondensation of α-2,8-linked sialic acids on NCAM is the result of a single enzymatic activity.","method":"Expression cloning, transfection, reconstitution in NCAM-expressing cell lines","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution experiment with cloned enzyme; >260 citations","pmids":["7854457"],"is_preprint":false},{"year":1995,"finding":"Expression cloning of a human polysialyltransferase (ST8SIA2/STX) that forms polysialylated NCAM present in embryonic brain. HeLa cells stably expressing polysialic acid and NCAM promoted neurite outgrowth and sprouting, indicating that polysialylated NCAM is critical for neural plasticity.","method":"Expression cloning, FACS sorting, stable transfection, neurite outgrowth assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — expression cloning with functional validation; >200 citations","pmids":["7624364"],"is_preprint":false},{"year":1997,"finding":"NCAM140 selectively co-immunoprecipitates with p59(fyn) from neonatal mouse cerebellum and transfected cells (NCAM180 and NCAM120 do not). NCAM activation (via antibody clustering or soluble NCAM fusion protein) recruits p125(fak) to the NCAM140-p59(fyn) complex and induces rapid transient tyrosine phosphorylation (activation) of both kinases, initiating a signaling cascade linked to growth cone migration.","method":"Co-immunoprecipitation from brain tissue and transfected cells, tyrosine phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP in native brain and transfected cells; isoform specificity demonstrated; >200 citations","pmids":["9079653"],"is_preprint":false},{"year":1997,"finding":"NCAM-deficient mice show severely impaired fasciculation and pathfinding of hippocampal mossy fiber axons, with alterations in mossy fiber terminal distribution, demonstrating that NCAM is essential for axonal growth, fasciculation, and maintenance of plasticity in the mature nervous system.","method":"Analysis of NCAM knockout mice (all isoforms), histology, axon tract tracing","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with defined anatomical phenotype; >240 citations","pmids":["9073395"],"is_preprint":false},{"year":1999,"finding":"Clustering of the NCAM140 isoform stimulates activation (dual phosphorylation) of ERK1/2 through a pathway involving p125fak, p59fyn, Ras, and MEK, and also induces phosphorylation of CREB at Ser133. Inhibition of the MAPK pathway selectively reduces NCAM-stimulated neurite outgrowth in cerebellar neurons.","method":"NCAM antibody clustering, kinase phosphorylation assays, specific pathway inhibitors, cerebellar neuron culture neurite outgrowth assay","journal":"Journal of neurobiology","confidence":"High","confidence_rationale":"Tier 2 — pathway dissection with multiple specific inhibitors and functional readout; >190 citations","pmids":["10084688"],"is_preprint":false},{"year":2000,"finding":"Crystal structure (1.85 Å) of the two N-terminal extracellular Ig-like domains of NCAM reveals a cross-shaped antiparallel dimer in molecular packing, providing the structural basis for homophilic trans-cellular recognition: NCAM forms cis-dimers that mediate low-affinity trans-interactions between cells in zipper-like arrays.","method":"X-ray crystallography","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 — 1.85 Å crystal structure with functional implication; >100 citations","pmids":["10802736"],"is_preprint":false},{"year":2002,"finding":"NCAM functions as a signaling receptor for GDNF family ligands independent of RET. NCAM associates with GFRα1 (GPI-anchored GDNF receptor), enabling high-affinity GDNF binding to p140(NCAM) and rapid activation of cytoplasmic kinases Fyn and FAK in RET-deficient cells. GDNF stimulates Schwann cell migration and hippocampal/cortical axonal growth via NCAM-Fyn activation.","method":"Co-immunoprecipitation, binding assays, kinase activation assays in RET-null cells, migration assay, neurite outgrowth assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in RET-deficient cells establishing a new signaling pathway; >475 citations","pmids":["12837245"],"is_preprint":false},{"year":2002,"finding":"Lipid raft association of NCAM140 is required for activation of the non-receptor tyrosine kinase pathway and neurite outgrowth. Mutation of NCAM140 palmitoylation sites or destruction of lipid rafts attenuates activation of FAK and ERK1/2, completely blocking neurite outgrowth. Cosignaling via both raft-associated kinases and the FGF receptor is essential for neuritogenesis.","method":"Hippocampal neuron transfection in NCAM-null mice, palmitoylation-site mutagenesis, methyl-β-cyclodextrin raft disruption, FGFR inhibitor, phospho-kinase assays, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis, pharmacological raft disruption, and specific FGFR inhibitor in NCAM-null background; >225 citations","pmids":["11980923"],"is_preprint":false},{"year":2003,"finding":"NCAM (120, 140, 180 isoforms) forms Triton X-100-insoluble complexes with βI spectrin in hippocampal neurons. βI spectrin binds directly to the intracellular domain of NCAM180 (and via lipid rafts to NCAM120). PKCβ2 forms complexes with NCAM140/NCAM180 and spectrin; NCAM activation enhances this complex and redistributes it to lipid rafts via FGFR. Dominant-negative βI spectrin fragment disrupts the complex and inhibits NCAM-induced neurite outgrowth.","method":"Co-immunoprecipitation, lipid raft fractionation, dominant-negative transfection, FGFR inhibitor, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, biochemical fractionation, and dominant-negative rescue with functional readout; >110 citations","pmids":["12743109"],"is_preprint":false},{"year":2003,"finding":"Direct interaction between NCAM fibronectin type III modules 1 and 2 and FGFR1 Ig modules 2 and 3 demonstrated by surface plasmon resonance. NMR structure of NCAM F3 module 2 shows overlapping binding sites for FGFR1 and ATP; ATP inhibits the NCAM-FGFR interaction and inhibits NCAM-induced neurite outgrowth, revealing ATP as a molecular switch regulating NCAM-FGFR signaling.","method":"Surface plasmon resonance, NMR structure determination, FGFR phosphorylation assay, neurite outgrowth assay","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — NMR structure + SPR binding + functional validation; >220 citations","pmids":["12791257"],"is_preprint":false},{"year":2004,"finding":"NCAM polysialylation increases intermembrane repulsion quantitatively by steric/ionic mechanisms, overwhelming both homophilic NCAM and cadherin-mediated attraction at physiological ionic strength. The repulsion is ionic-strength dependent and PSA-dose dependent, revealing the molecular mechanism by which PSA-NCAM regulates cell adhesion.","method":"Molecular force measurements (surface force apparatus) on membrane-bound NCAM","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative biophysical reconstitution with cadherin controls; >180 citations","pmids":["15504723"],"is_preprint":false},{"year":2004,"finding":"NCAM140 directly interacts with the intracellular domain of RPTPα, a known activator of p59fyn. NCAM activation promotes Ca2+-dependent spectrin-mediated crosslinking of NCAM and RPTPα and redistributes the complex to lipid rafts. RPTPα-deficient neurons lose NCAM-p59fyn association and NCAM-mediated p59fyn activation, blocking NCAM-dependent neurite outgrowth.","method":"Co-immunoprecipitation, RPTPα-knockout neurons, dominant-negative RPTPα, lipid raft fractionation, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic (KO), biochemical (co-IP), and dominant-negative approaches converge on same phenotype; >95 citations","pmids":["15623578"],"is_preprint":false},{"year":2006,"finding":"Metalloprotease-induced ectodomain shedding of NCAM140 releases a 115-kDa soluble fragment. Shedding is induced by the tyrosine phosphatase inhibitor pervanadate via an ADAM metalloprotease regulated by ERK1/2. Metalloprotease inhibitor GM6001 increases NCAM-dependent neurite branching and outgrowth; a transgenic NCAM-shedding mouse model shows impaired neuronal connectivity.","method":"NCAM transfection in L-fibroblasts, pharmacological inhibitors, metalloprotease inhibitors, transgenic mouse model, neurite outgrowth assay","journal":"Journal of neurobiology","confidence":"High","confidence_rationale":"Tier 2 — pharmacological dissection and transgenic model with functional readout; >90 citations","pmids":["16967505"],"is_preprint":false},{"year":2007,"finding":"ST8SiaIV is the major regulator of NCAM polysialylation in vivo. Analysis of mice lacking ST8SiaII or ST8SiaIV shows that both enzymes polysialylate N-glycosylation sites 5 and 6 of NCAM with the same glycan sets, but ST8SiaII and ST8SiaIV act synergistically to produce long polySia chains at site 5; ST8SiaIV alone yields shorter chains.","method":"Analysis of polysialyltransferase knockout mice, glycopeptide mass spectrometry, polySia chain-length analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo genetic models with detailed glycan structure analysis","pmids":["17986444"],"is_preprint":false},{"year":2008,"finding":"NCAM clustering at the cell surface is coupled to Ca2+ influx via T- and L-type voltage-dependent Ca2+ channels associated with NCAM, activation of CaMKIIα, and serine phosphorylation of RPTPα at Ser180 and Ser204, increasing RPTPα phosphatase activity. Mutation of these serine residues interferes with NCAM-induced neurite outgrowth, establishing a novel NCAM→Ca2+ channel→CaMKIIα→RPTPα→neurite outgrowth cascade.","method":"NCAM clustering assay, Ca2+ channel co-IP, CaMKIIα activation assay, RPTPα serine phosphorylation, dominant-negative/mutant transfection, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic cascade identified through co-IP, pharmacology, mutagenesis, and functional readout","pmids":["18809727"],"is_preprint":false},{"year":2008,"finding":"GAP-43 phosphorylation by PKC or CKII potentiates NCAM-180/spectrin-mediated neurite outgrowth. In the presence of GAP-43, NCAM-180/spectrin/GAP-43 association is required; in its absence, the NCAM-140/Fyn pathway dominates. GAP-43 thus acts as a molecular switch that determines the predominant NCAM signaling mechanism.","method":"GAP-43 overexpression, phosphorylation mutants, dominant-negative betaI spectrin, neurite outgrowth assay in PC12 and hippocampal neurons","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mutant constructs and functional readout, single laboratory","pmids":["17212696"],"is_preprint":false},{"year":2008,"finding":"NCAM-mediated ERK phosphorylation requires FGFR, Src-family kinases, MEK, and Gi/G0-proteins; NCAM-mediated CREB phosphorylation requires Src-family kinases and MEK; NCAM-mediated Akt phosphorylation requires cGMP and PI3K. These pathways are independent of PLC, PKC, PKA, and CaMKII, revealing a specific signaling hierarchy downstream of NCAM.","method":"NCAM ligand (C3d peptide) stimulation of cerebellar granule neurons, specific pathway inhibitors, phospho-kinase assays","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 — systematic pharmacological pathway dissection; single laboratory","pmids":["18656513"],"is_preprint":false},{"year":2009,"finding":"Neuronal membrane depolarization triggers skipping of NCAM exon 18, independently of the CaMKIV pathway. This splicing change is regulated by RNA Pol II elongation rate and is accompanied by H3K9 hyper-acetylation restricted to the intragenic region surrounding exon 18, without promoter acetylation changes; effects are reversible and potentiated by HDAC inhibitor TSA.","method":"Neuronal depolarization, RT-PCR splicing assay, slow Pol II mutant, ChIP for H3K9ac and H3K36me3, HDAC inhibitor","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (slow polymerase mutant, ChIP, pharmacological) establishing mechanism; >220 citations","pmids":["19251664"],"is_preprint":false},{"year":2011,"finding":"NCAM promotes ovarian cancer cell migration and peritoneal metastasis via direct interaction with FGFR. FGFR signaling is required for NCAM-induced cell motility, and a monoclonal antibody targeting the NCAM/FGFR interplay abolishes metastatic dissemination in mice.","method":"In vitro migration/invasion assays, FGFR inhibition, anti-NCAM monoclonal antibody, mouse peritoneal metastasis model","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo validation with antibody blockade; >65 citations","pmids":["21739604"],"is_preprint":false},{"year":2013,"finding":"Intragenic repressive chromatin marks (H3K9me2, H3K27me3) increase along the NCAM gene body during neuronal differentiation, correlating with inhibition of Pol II elongation in the exon 18 region and increased exon 18 inclusion. Intronic siRNAs targeting NCAM intron 18 induce H3K9me2 and promote E18 inclusion in undifferentiated cells, confirming that intragenic chromatin deployment is sufficient to alter NCAM alternative splicing.","method":"ChIP for H3K9me2/H3K27me3, 5-azacytidine and BIX01294 inhibition, intronic siRNA-directed chromatin changes, RT-PCR splicing assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — pharmacological, siRNA-epigenetic, and ChIP approaches converge; >75 citations","pmids":["23892457"],"is_preprint":false},{"year":2013,"finding":"NeuroD1 transcriptionally regulates NCAM expression in neuroendocrine lung carcinomas; impaired NeuroD1 expression mirrors loss of NCAM, and NCAM is a downstream target of NeuroD1 that promotes tumor cell survival and metastasis.","method":"NeuroD1 knockdown/overexpression, gene expression analysis, cell survival and migration assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — genetic perturbation with functional readouts, single laboratory","pmids":["23553831"],"is_preprint":false},{"year":2017,"finding":"GFRα1 directly interacts with NCAM in embryonic Purkinje cells. Genetic reduction of NCAM expression enhances wild-type Purkinje cell migration and rescues delayed migration in Gfra1 mutants, demonstrating that NCAM restricts Purkinje cell migration and that GFRα1 promotes migration by limiting NCAM function in cis and trans.","method":"Co-immunoprecipitation, Gfra1/NCAM genetic mutants, in vitro migration assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (double mutant rescue) plus co-IP and in vitro functional assay","pmids":["28076782"],"is_preprint":false},{"year":2017,"finding":"TGFβ1 induces NCAM1 expression in cardiomyocytes via a p38-dependent pathway; selective targeting of NCAM1 rescues the cell-cell adhesion defect caused by TGFβ1. NCAM1 protein levels correlate with TGFβ1 activity in human cardiomyopathy samples.","method":"Cardiac-specific TGFβ1 transgenic mice, electron microscopy, p38 inhibition, NCAM1 siRNA, immunostaining","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic model plus pharmacological and siRNA interventions with functional rescue","pmids":["28870505"],"is_preprint":false},{"year":2018,"finding":"Peripheral nerve injury activates the anterior cingulate cortex (ACC) and increases turnover of NCAM1 at synapses. NCAM1 mediates dendritic spine reorganization in the ACC and contributes to behavioral sensitization after nerve injury through a mechanism parallel to NMDA-receptor- and protein-synthesis-dependent LTP.","method":"Peripheral nerve injury model, synaptic protein turnover analysis, spine morphology, behavioral assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined synaptic and behavioral phenotype, single laboratory","pmids":["29346771"],"is_preprint":false},{"year":2019,"finding":"NCAM1 regulates AML cell survival and stress resistance. Loss of NCAM1 induces cell death or differentiation and sensitizes blasts to genotoxic agents. NCAM1 expression is associated with constitutive activation of the MAPK pathway; MEK1/2 inhibition specifically sensitizes NCAM1+ AML cells to chemotherapy. Depletion of Ncam1 in a murine leukemia model reduced leukemia-initiating cells and prolonged disease latency.","method":"Genetic knockdown/knockout (NCAM1), phosphoproteomics, transcriptomics, in vitro cytotoxicity assays, murine transplantation model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — complementary genetic strategies, phosphoproteomics, and in vivo murine leukemia model","pmids":["30814062"],"is_preprint":false},{"year":2020,"finding":"NCAM1 functions as a receptor for Zika virus (ZIKV) entry. Chemical proteomic photocrosslinking identified NCAM1 as a ZIKV-interacting protein; overexpression of NCAM1 enhanced ZIKV infection while knockout and inhibition reduced it in Vero and U-251 MG cells.","method":"Chemical proteomics (photocrosslinking + biotin enrichment + MS), NCAM1 overexpression, knockout, and inhibition, infection assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — discovery by chemical proteomics validated by gain- and loss-of-function in two cell lines","pmids":["32753727"],"is_preprint":false},{"year":2020,"finding":"CD56 (NCAM1) deletion in NK92 cells impairs cytotoxic function, lytic granule exocytosis, and immunological synapse polarization. Phosphorylation of the FAK family member Pyk2 at Tyr402 is decreased in CD56-KO cells; reintroduction of CD56 rescues cytotoxicity, exocytosis, and Pyk2 phosphorylation, establishing a functional link between NCAM1 and Pyk2 signaling in NK cell cytotoxicity.","method":"CRISPR-Cas9 knockout of CD56 in NK92, lytic granule exocytosis assay, immunological synapse assay, phospho-Pyk2 immunoblot, CD56 rescue transfection","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — clean KO with genetic rescue and multiple functional readouts","pmids":["32510326"],"is_preprint":false},{"year":2022,"finding":"Anti-NCAM1 autoantibodies from schizophrenia patients disrupt NCAM1-NCAM1 homophilic binding, NCAM1-GDNF, and NCAM1-Fyn interactions. Intracerebrospinal introduction into mice inhibits FAK, MEK1, and ERK1 phosphorylation, reduces spine and synapse number in frontal cortex, and induces schizophrenia-related behavior (deficient pre-pulse inhibition, cognitive impairment).","method":"Cell-based autoantibody assay, ELISA, in vitro interaction blocking assays, intrathecal antibody injection in mice, immunofluorescence (spine/synapse density), behavioral assays","journal":"Cell reports. Medicine","confidence":"High","confidence_rationale":"Tier 2 — patient-derived antibody with defined molecular targets and in vivo behavioral validation","pmids":["35492247"],"is_preprint":false},{"year":2023,"finding":"KLK8 (a serine protease) proteolytically cleaves the extracellular domain of NCAM1 in hippocampal neurons, decreasing NCAM1 surface expression. Transgenic KLK8 overexpression exacerbates CUMS-induced hippocampal neuronal apoptosis and depression-like behavior; KLK8 deficiency prevents NCAM1 loss. Both NCAM1 overexpression and an NCAM1 mimetic peptide rescue KLK8-overexpressing neurons from apoptosis.","method":"KLK8 transgenic and KO mice, CUMS model, adenoviral NCAM1 overexpression, co-immunoprecipitation, protease cleavage assay, NCAM1 mimetic peptide rescue, immunofluorescence","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — genetic gain- and loss-of-function, biochemical cleavage assay, and functional rescue","pmids":["37076499"],"is_preprint":false},{"year":2000,"finding":"PSA-NCAM directly interacts with BDNF. Enzymatic removal of PSA (Endo-N) or NCAM knockout reduces LTP in hippocampal CA1 and reduces TrkB phosphorylation. Exogenous BDNF restores deficient LTP in both NCAM-KO and Endo-N-treated slices, suggesting that PSA-NCAM sensitizes pyramidal neurons to BDNF to modulate activity-dependent synaptic plasticity.","method":"NCAM knockout mice, Endo-N enzymatic PSA removal, organotypic hippocampal slice LTP recordings, BDNF rescue, TrkB phosphorylation assay, PSA-NCAM binding to BDNF","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic KO and enzymatic ablation converge; BDNF rescue and TrkB phosphorylation data; >175 citations","pmids":["10760298"],"is_preprint":false}],"current_model":"NCAM1 is a multifunctional immunoglobulin-superfamily cell adhesion molecule that mediates homophilic cell-cell adhesion through cis-dimerization and zipper-like trans-interactions of its five Ig-like extracellular domains, with adhesion strength controlled by polysialylation (via ST8SIA2/ST8SIA4) that exerts steric/ionic repulsion; upon homophilic or heterophilic engagement, the NCAM140 isoform—whose raft association depends on palmitoylation—recruits RPTPα, which activates p59(fyn) and p125(FAK), triggering the Ras→MEK→ERK1/2 cascade and CREB phosphorylation to drive neurite outgrowth, while additionally serving as a co-receptor for GDNF via GFRα1 (activating Fyn/FAK independently of RET), interacting directly with FGFR1 through its fibronectin type III modules (regulated by ATP), being subject to ADAM metalloprotease ectodomain shedding regulated by ERK, and undergoing activity-dependent alternative splicing through intragenic epigenetic changes; in NK cells NCAM1 engages Pyk2 to promote lytic granule exocytosis, and in AML it sustains leukemic stem cell survival via constitutive MAPK activation."},"narrative":{"teleology":[{"year":1987,"claim":"Molecular cloning resolved NCAM's domain architecture—five Ig-like extracellular domains shared by three major isoforms (120, 140, 180 kDa)—and established that homophilic binding resides in the Ig domains while isoform diversity arises from alternative splicing of cytoplasmic segments, providing the structural framework for all subsequent signaling studies.","evidence":"cDNA cloning and amino acid sequencing of CNBr/proteolytic fragments, Northern blot; additional tissue-specific (muscle MSD1) and secreted isoforms identified by cDNA cloning","pmids":["3576199","2887295","3203385"],"confidence":"High","gaps":["Three-dimensional structure of the full extracellular domain was not yet determined","Cytoplasmic signaling partners unknown"]},{"year":1988,"claim":"Functional experiments demonstrated that polysialic acid (PSA) on NCAM generates steric exclusion that inhibits membrane apposition and cell–cell contact, establishing PSA as a negative regulator of NCAM-mediated adhesion rather than a binding enhancer.","evidence":"Cell adhesion assays with enzymatic PSA removal and antibody blocking","pmids":["3281256"],"confidence":"High","gaps":["Identity of polysialyltransferase(s) unknown","Quantitative biophysical characterization of repulsion pending"]},{"year":1993,"claim":"Discovery that NCAM's fourth Ig domain binds L1 glycans in cis via a lectin-like motif, and that transmembrane NCAM isoforms regulate MMP secretion, expanded NCAM's role beyond simple adhesion to heterophilic cis-signaling and extracellular matrix remodeling.","evidence":"Co-IP, recombinant domain binding, peptide inhibition of L1–NCAM, neurite outgrowth assay; transfection of glioma cells with isoform-specific constructs and MMP zymography","pmids":["8509458","8265575"],"confidence":"High","gaps":["Structural basis of L1–NCAM cis-complex unresolved","Downstream effectors linking NCAM to MMP gene regulation unknown"]},{"year":1995,"claim":"Cloning of polysialyltransferases PST-1 and ST8SIA2 and reconstitution of PSA synthesis on NCAM in vitro identified the enzymes responsible for NCAM polysialylation, enabling subsequent genetic dissection of PSA function.","evidence":"Expression cloning, in vitro enzymatic reconstitution with defined NCAM substrates, stable transfection in NCAM-expressing cell lines","pmids":["7854457","8805371","7624364"],"confidence":"High","gaps":["Relative contributions of the two polysialyltransferases in vivo not yet resolved","Chain-length control mechanism unknown"]},{"year":1997,"claim":"Identification of p59fyn and p125FAK as isoform-selective (NCAM140-specific) signaling effectors, together with the demonstration that NCAM-knockout mice have severe mossy fiber pathfinding defects, connected NCAM to intracellular kinase cascades and established its in vivo requirement for axon guidance.","evidence":"Co-IP from neonatal brain and transfected cells, tyrosine phosphorylation assays; NCAM-knockout mouse histology and tract tracing","pmids":["9079653","9073395"],"confidence":"High","gaps":["Mechanism linking Fyn/FAK to cytoskeletal remodeling unknown","How NCAM140 selectively recruits Fyn (not NCAM180 or 120) unclear"]},{"year":1999,"claim":"Full Ras→MEK→ERK1/2→CREB pathway downstream of NCAM140 was mapped, and MEK inhibition selectively blocked NCAM-driven neurite outgrowth, establishing MAPK as the principal effector cascade for NCAM-dependent neuritogenesis.","evidence":"NCAM antibody clustering, specific MEK/Ras inhibitors, phospho-kinase assays, cerebellar neuron neurite outgrowth","pmids":["10084688"],"confidence":"High","gaps":["Parallel PI3K/Akt and cGMP branches not yet placed in signaling hierarchy","Nuclear transcriptional targets of CREB downstream of NCAM undefined"]},{"year":2000,"claim":"Crystal structure of the two N-terminal Ig domains revealed antiparallel cis-dimers that assemble into zipper-like trans-arrays, providing the first atomic model of homophilic NCAM recognition; concurrently, PSA-NCAM was shown to bind BDNF and modulate hippocampal LTP via TrkB.","evidence":"X-ray crystallography at 1.85 Å; NCAM-KO and Endo-N-treated hippocampal slices with BDNF rescue and TrkB phosphorylation","pmids":["10802736","10760298"],"confidence":"High","gaps":["Structure of full-length extracellular region (all five Ig + FNIII domains) not determined","Direct PSA–BDNF binding site unmapped"]},{"year":2002,"claim":"Two parallel signaling axes were delineated: palmitoylation-dependent lipid-raft localization of NCAM140 was shown essential for Fyn/FAK/ERK activation, and NCAM was identified as a RET-independent co-receptor for GDNF via GFRα1, activating Fyn/FAK in RET-null cells to promote Schwann cell migration and axon growth.","evidence":"Palmitoylation-site mutagenesis, raft disruption (MβCD), FGFR inhibitor in NCAM-null hippocampal neurons; co-IP and kinase assays in RET-deficient cells, migration and neurite outgrowth assays","pmids":["11980923","12837245"],"confidence":"High","gaps":["Whether GDNF–NCAM and FGFR–NCAM pathways converge or remain independent unclear","Palmitoylation enzyme(s) for NCAM not identified"]},{"year":2003,"claim":"NMR and SPR experiments mapped the direct NCAM–FGFR1 binding interface to NCAM FNIII modules 1–2 and FGFR1 Ig2–3, and revealed that extracellular ATP competes for the same NCAM surface, acting as a molecular switch that inhibits NCAM–FGFR signaling and neurite outgrowth.","evidence":"NMR structure of NCAM F3 module 2, surface plasmon resonance, FGFR phosphorylation and neurite outgrowth assays","pmids":["12791257"],"confidence":"High","gaps":["Physiological regulation of local ATP concentration at the NCAM–FGFR interface unknown","Whether ATP regulation applies to all NCAM-expressing cell types untested"]},{"year":2003,"claim":"NCAM signals through a spectrin–PKCβ2 scaffold that is redistributed to lipid rafts in an FGFR-dependent manner; disrupting this scaffold with dominant-negative βI spectrin blocked neurite outgrowth, linking cytoskeletal adaptor assembly to NCAM function.","evidence":"Co-IP, lipid raft fractionation, dominant-negative βI spectrin transfection, FGFR inhibitor, neurite outgrowth assay in hippocampal neurons","pmids":["12743109"],"confidence":"High","gaps":["How spectrin crosslinking mechanically couples to growth cone advance not defined","Structural basis of NCAM180–spectrin interaction unknown"]},{"year":2004,"claim":"Quantitative biophysical force measurements showed that PSA overwhelms both NCAM homophilic and cadherin-mediated attraction at physiological ionic strength, while RPTPα was identified as the direct bridge linking NCAM140 to Fyn activation, with RPTPα-knockout neurons losing NCAM-dependent signaling.","evidence":"Surface force apparatus on reconstituted membranes; RPTPα-KO neurons, dominant-negative RPTPα, co-IP, lipid raft fractionation, neurite outgrowth","pmids":["15504723","15623578"],"confidence":"High","gaps":["Crystal structure of NCAM–RPTPα complex not determined","Whether PSA removal fully restores adhesive strength in vivo unclear"]},{"year":2007,"claim":"In vivo analysis of ST8SiaII and ST8SiaIV knockout mice resolved their relative contributions: both enzymes modify NCAM glycosylation sites 5 and 6, but synergize to produce long polySia chains, with ST8SiaIV as the dominant modifier.","evidence":"Polysialyltransferase-KO mice, glycopeptide mass spectrometry, polySia chain-length analysis","pmids":["17986444"],"confidence":"High","gaps":["Determinants of site-specific polysialyltransferase recruitment unresolved","Chain-length termination mechanism unknown"]},{"year":2008,"claim":"A Ca²⁺-dependent signaling branch was uncovered: NCAM clustering opens T/L-type Ca²⁺ channels, activating CaMKIIα, which phosphorylates RPTPα at Ser180/204 to boost its phosphatase activity, establishing a parallel Ca²⁺→CaMKII→RPTPα→Fyn cascade for neurite outgrowth.","evidence":"NCAM clustering, Ca²⁺ channel co-IP, CaMKIIα activation, RPTPα serine-phosphorylation mutants, neurite outgrowth in hippocampal neurons","pmids":["18809727"],"confidence":"High","gaps":["Identity of T/L-type channel subunits complexed with NCAM not defined","How this Ca²⁺ branch integrates with Ras–MAPK signaling quantitatively unknown"]},{"year":2009,"claim":"Activity-dependent alternative splicing of NCAM exon 18 was shown to be governed by intragenic epigenetic changes: membrane depolarization induces H3K9 hyperacetylation at the exon 18 locus, altering RNA Pol II elongation rate and exon inclusion, establishing a novel chromatin-based splicing switch.","evidence":"Neuronal depolarization, RT-PCR splicing, slow Pol II mutant, ChIP for H3K9ac/H3K36me3, HDAC inhibitor TSA; later confirmed by intragenic repressive marks (H3K9me2, H3K27me3) and intronic siRNA-directed chromatin remodeling during differentiation","pmids":["19251664","23892457"],"confidence":"High","gaps":["Chromatin reader and splicing factor that interpret the marks not identified","Whether this mechanism operates in non-neuronal NCAM-expressing cells unknown"]},{"year":2006,"claim":"ADAM metalloprotease-mediated ectodomain shedding of NCAM140, regulated by ERK1/2, was identified as a physiological modulator of neurite outgrowth and connectivity, with a transgenic shedding model showing impaired neuronal connectivity.","evidence":"Pharmacological inhibitors, metalloprotease inhibitors, transgenic NCAM-shedding mouse, neurite outgrowth assay","pmids":["16967505"],"confidence":"High","gaps":["Specific ADAM family member(s) responsible not identified","Whether shed NCAM acts as a soluble ligand or simply removes receptor unknown"]},{"year":2019,"claim":"In AML, NCAM1 was found to sustain leukemia-initiating cell survival via constitutive MAPK activation; genetic depletion induced differentiation or death and sensitized blasts to chemotherapy, repositioning NCAM1 as a therapeutic target outside the nervous system.","evidence":"Genetic knockdown/KO, phosphoproteomics, transcriptomics, murine transplantation leukemia model, MEK1/2 inhibitor sensitization","pmids":["30814062"],"confidence":"High","gaps":["Mechanism of constitutive MAPK activation by NCAM1 in AML (ligand-independent?) unclear","Whether anti-NCAM1 therapy is effective without chemotherapy combination unknown"]},{"year":2020,"claim":"Two non-neural roles were established: NCAM1 was identified as a Zika virus entry receptor by chemical proteomics, and CRISPR knockout in NK cells demonstrated that NCAM1 drives lytic granule exocytosis and immunological synapse polarization via Pyk2 Tyr402 phosphorylation.","evidence":"Photocrosslinking chemical proteomics, NCAM1 overexpression/KO infection assays (Zika); CRISPR-Cas9 KO in NK92 cells with CD56 rescue, phospho-Pyk2 immunoblot, granule exocytosis and synapse assays","pmids":["32753727","32510326"],"confidence":"High","gaps":["ZIKV binding site on NCAM1 extracellular domain not mapped","Whether Pyk2 binds NCAM1 directly or via an adaptor unknown"]},{"year":2022,"claim":"Patient-derived anti-NCAM1 autoantibodies disrupted homophilic binding, GDNF interaction, and Fyn signaling, and when introduced intrathecally in mice, reduced FAK/MEK/ERK phosphorylation, spine/synapse density, and caused schizophrenia-related behaviors, providing causal evidence linking NCAM1 signaling disruption to psychiatric disease.","evidence":"Patient autoantibody characterization, in vitro interaction blocking, intracerebrospinal injection in mice, spine/synapse immunofluorescence, pre-pulse inhibition and cognitive behavioral assays","pmids":["35492247"],"confidence":"High","gaps":["Epitope specificity of pathogenic autoantibodies not mapped at residue level","Whether anti-NCAM1 autoantibodies are causative or secondary in schizophrenia patients unresolved"]},{"year":2023,"claim":"KLK8 serine protease was identified as a novel extracellular protease that cleaves NCAM1, reducing surface expression in hippocampal neurons; NCAM1 overexpression or a mimetic peptide rescued KLK8-driven neuronal apoptosis and depression-like behavior.","evidence":"KLK8 transgenic/KO mice, CUMS model, protease cleavage assay, co-IP, adenoviral NCAM1 overexpression and mimetic peptide rescue","pmids":["37076499"],"confidence":"High","gaps":["KLK8 cleavage site on NCAM1 not determined","Whether KLK8-mediated NCAM1 shedding generates a bioactive soluble fragment unknown"]},{"year":null,"claim":"Key unresolved questions include the full-length extracellular domain structure in a membrane context, how NCAM1's multiple signaling arms (FGFR, GFRα1/GDNF, RPTPα/Fyn, Ca²⁺/CaMKII, Pyk2) are integrated spatiotemporally, the identity and regulation of palmitoylation enzymes for NCAM, the structural basis of the NCAM1–Pyk2 connection in NK cells, and whether NCAM1 can be therapeutically targeted in AML or as a viral entry receptor without neurological consequences.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length ectodomain structure in lipid bilayer context","Quantitative model integrating parallel signaling cascades lacking","Therapeutic window for NCAM1 targeting in cancer/infection versus neural side effects undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,3,14,19]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[11,13,15,16]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[15,30]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[34]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,14,16,20,35]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,13,15,16,18,20,23,25,33,35]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,3,14,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,7,12,30]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[12,13,32,38]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[35]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[27,33,34]}],"complexes":[],"partners":["FGFR1","PTPRA","FYN","PTK2","GFRA1","SPTBN1","PTK2B","L1CAM"],"other_free_text":[]},"mechanistic_narrative":"NCAM1 is a multifunctional immunoglobulin-superfamily cell adhesion molecule that mediates homophilic and heterophilic cell–cell interactions critical for neural development, synaptic plasticity, and immune cell cytotoxicity. Its extracellular region contains five Ig-like domains that form cis-dimers and zipper-like trans-interactions, with adhesion strength negatively regulated by polysialylation (catalyzed by ST8SIA2 and ST8SIA4) through steric and ionic repulsion [PMID:10802736, PMID:15504723, PMID:17986444]. The NCAM140 isoform, whose lipid-raft association depends on palmitoylation, recruits RPTPα to activate Fyn and FAK, triggering Ras→MEK→ERK1/2 and CREB phosphorylation to drive neurite outgrowth; NCAM additionally signals through direct binding to FGFR1 via its fibronectin type III modules and serves as a RET-independent GDNF co-receptor via GFRα1, activating Fyn/FAK in Schwann cells and neurons [PMID:9079653, PMID:10084688, PMID:12791257, PMID:12837245, PMID:11980923]. Beyond the nervous system, NCAM1 promotes NK-cell lytic granule exocytosis through Pyk2 signaling and sustains leukemic stem cell survival in AML via constitutive MAPK activation [PMID:32510326, PMID:30814062]."},"prefetch_data":{"uniprot":{"accession":"P13591","full_name":"Neural cell adhesion molecule 1","aliases":[],"length_aa":858,"mass_kda":94.6,"function":"This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc (Microbial infection) Acts as a receptor for rabies virus (Microbial infection) Acts as a receptor for Zika virus","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P13591/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NCAM1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":77,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NCAM1","total_profiled":1310},"omim":[{"mim_id":"617150","title":"ZDHHC PALMITOYLTRANSFERASE 3; ZDHHC3","url":"https://www.omim.org/entry/617150"},{"mim_id":"615669","title":"EMBIGIN; EMB","url":"https://www.omim.org/entry/615669"},{"mim_id":"614172","title":"IMMUNODEFICIENCY 21; IMD21","url":"https://www.omim.org/entry/614172"},{"mim_id":"613961","title":"TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19","url":"https://www.omim.org/entry/613961"},{"mim_id":"610648","title":"CUT-LIKE HOMEOBOX 2; CUX2","url":"https://www.omim.org/entry/610648"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":187.4},{"tissue":"heart muscle","ntpm":136.4}],"url":"https://www.proteinatlas.org/search/NCAM1"},"hgnc":{"alias_symbol":["NCAM","CD56"],"prev_symbol":[]},"alphafold":{"accession":"P13591","domains":[{"cath_id":"2.60.40.10","chopping":"20-114","consensus_level":"high","plddt":86.5562,"start":20,"end":114},{"cath_id":"2.60.40.10","chopping":"118-208","consensus_level":"medium","plddt":89.6596,"start":118,"end":208},{"cath_id":"2.60.40.10","chopping":"217-304","consensus_level":"medium","plddt":92.3322,"start":217,"end":304},{"cath_id":"2.60.40.10","chopping":"314-350_360-413","consensus_level":"medium","plddt":86.6123,"start":314,"end":413},{"cath_id":"2.60.40.10","chopping":"420-505","consensus_level":"medium","plddt":93.4486,"start":420,"end":505},{"cath_id":"2.60.40.10","chopping":"513-604","consensus_level":"high","plddt":93.9135,"start":513,"end":604},{"cath_id":"2.60.40.10","chopping":"615-700","consensus_level":"high","plddt":89.6224,"start":615,"end":700}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13591","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-predicted_aligned_error_v6.png","plddt_mean":79.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NCAM1","jax_strain_url":"https://www.jax.org/strain/search?query=NCAM1"},"sequence":{"accession":"P13591","fasta_url":"https://rest.uniprot.org/uniprotkb/P13591.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13591/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13591"}},"corpus_meta":[{"pmid":"2471777","id":"PMC_2471777","title":"Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2471777","citation_count":467,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17029752","id":"PMC_17029752","title":"PSA-NCAM in mammalian structural plasticity and neurogenesis.","date":"2006","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17029752","citation_count":352,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11861268","id":"PMC_11861268","title":"Clinical and biologic features of CD4(+)CD56(+) malignancies.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861268","citation_count":317,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9073395","id":"PMC_9073395","title":"NCAM is essential for axonal growth and fasciculation in the hippocampus.","date":"1997","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/9073395","citation_count":244,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11980923","id":"PMC_11980923","title":"Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11980923","citation_count":228,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19251664","id":"PMC_19251664","title":"Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19251664","citation_count":223,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10084688","id":"PMC_10084688","title":"NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells.","date":"1999","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10084688","citation_count":190,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15504723","id":"PMC_15504723","title":"Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15504723","citation_count":181,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15662836","id":"PMC_15662836","title":"Zippers make signals: NCAM-mediated molecular interactions and signal transduction.","date":"2004","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/15662836","citation_count":162,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9951628","id":"PMC_9951628","title":"The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system.","date":"1998","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/9951628","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17085484","id":"PMC_17085484","title":"Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17085484","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2179732","id":"PMC_2179732","title":"Enhanced myogenesis in NCAM-transfected mouse myoblasts.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2179732","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"13130309","id":"PMC_13130309","title":"What is CD4+CD56+ malignancy and how should it be treated?","date":"2003","source":"Bone marrow transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/13130309","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7526680","id":"PMC_7526680","title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.","date":"1994","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/7526680","citation_count":137,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16045455","id":"PMC_16045455","title":"Structural biology of NCAM homophilic binding and activation of FGFR.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16045455","citation_count":136,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17439829","id":"PMC_17439829","title":"CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.","date":"2007","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17439829","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17986140","id":"PMC_17986140","title":"Dissecting polysialic acid and NCAM functions in brain development.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17986140","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11831554","id":"PMC_11831554","title":"Revisiting the function of PSA-NCAM in the nervous system.","date":"2001","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/11831554","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12743109","id":"PMC_12743109","title":"Neural cell adhesion molecule (NCAM) association with PKCbeta2 via betaI spectrin is implicated in NCAM-mediated neurite outgrowth.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12743109","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1623208","id":"PMC_1623208","title":"NCAM: structural diversity, function and regulation of expression.","date":"1992","source":"Seminars in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1623208","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17761687","id":"PMC_17761687","title":"Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17761687","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10802736","id":"PMC_10802736","title":"Structural basis of cell-cell adhesion by NCAM.","date":"2000","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/10802736","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1721526","id":"PMC_1721526","title":"Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.","date":"1991","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1721526","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15623578","id":"PMC_15623578","title":"RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15623578","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16967505","id":"PMC_16967505","title":"Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM).","date":"2006","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16967505","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23354723","id":"PMC_23354723","title":"Polysialic acid: versatile modification of NCAM, SynCAM 1 and neuropilin-2.","date":"2013","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/23354723","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23553831","id":"PMC_23553831","title":"NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23553831","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11841427","id":"PMC_11841427","title":"Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma.","date":"2002","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11841427","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9215693","id":"PMC_9215693","title":"Increased intermale aggression and neuroendocrine response in mice deficient for the neural cell adhesion molecule (NCAM).","date":"1997","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9215693","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18828801","id":"PMC_18828801","title":"Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/18828801","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18308302","id":"PMC_18308302","title":"Neural cell adhesion molecule (NCAM) marks adult myogenic cells committed to differentiation.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18308302","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30814062","id":"PMC_30814062","title":"NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.","date":"2019","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30814062","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23892457","id":"PMC_23892457","title":"Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23892457","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15353284","id":"PMC_15353284","title":"Molecular mechanisms of NCAM function.","date":"2004","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/15353284","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8265575","id":"PMC_8265575","title":"Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8265575","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8805371","id":"PMC_8805371","title":"Polysialylation of NCAM by a single enzyme.","date":"1996","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/8805371","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21739604","id":"PMC_21739604","title":"The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.","date":"2011","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21739604","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8163558","id":"PMC_8163558","title":"Expression of NCAM containing VASE in neurons can account for a developmental loss in their neurite outgrowth response to NCAM in a cellular substratum.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8163558","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9215735","id":"PMC_9215735","title":"Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head.","date":"1997","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/9215735","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17212696","id":"PMC_17212696","title":"GAP-43 regulates NCAM-180-mediated neurite outgrowth.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17212696","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23303482","id":"PMC_23303482","title":"ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure.","date":"2013","source":"JAMA psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23303482","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8501910","id":"PMC_8501910","title":"Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer.","date":"1993","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/8501910","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12183105","id":"PMC_12183105","title":"Cadherins and NCAM as potential targets in metal toxicity.","date":"2002","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12183105","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14742908","id":"PMC_14742908","title":"NCAM mimetic peptides: Pharmacological and therapeutic potential.","date":"2004","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/14742908","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1706237","id":"PMC_1706237","title":"Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.","date":"1991","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1706237","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7643959","id":"PMC_7643959","title":"Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling.","date":"1995","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/7643959","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17986444","id":"PMC_17986444","title":"Enzyme-dependent variations in the polysialylation of the neural cell adhesion molecule (NCAM) in vivo.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17986444","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26478212","id":"PMC_26478212","title":"L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets.","date":"2015","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26478212","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37563308","id":"PMC_37563308","title":"Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37563308","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23780867","id":"PMC_23780867","title":"The dendritic spines of interneurons are dynamic structures influenced by PSA-NCAM expression.","date":"2013","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/23780867","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32510326","id":"PMC_32510326","title":"CD56 regulates human NK cell cytotoxicity through Pyk2.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32510326","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8752917","id":"PMC_8752917","title":"A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8752917","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32753727","id":"PMC_32753727","title":"Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32753727","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7824058","id":"PMC_7824058","title":"Regional changes in expression of NCAM, GFAP, and S100 in aging rat brain.","date":"1994","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/7824058","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15914364","id":"PMC_15914364","title":"CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.","date":"2005","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/15914364","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29346771","id":"PMC_29346771","title":"Rapid Turnover of Cortical NCAM1 Regulates Synaptic Reorganization after Peripheral Nerve Injury.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29346771","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15466379","id":"PMC_15466379","title":"Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.","date":"2004","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15466379","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17573672","id":"PMC_17573672","title":"Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells.","date":"2007","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17573672","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7692192","id":"PMC_7692192","title":"Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.","date":"1993","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/7692192","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7512851","id":"PMC_7512851","title":"NCAM (CD56)-positive malignant lymphoma.","date":"1993","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/7512851","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8462735","id":"PMC_8462735","title":"A functional role for the middle extracellular region of the neural cell adhesion molecule (NCAM) in axonal fasciculation and orientation.","date":"1993","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8462735","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18213713","id":"PMC_18213713","title":"Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.","date":"2008","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18213713","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8792212","id":"PMC_8792212","title":"The neural cell adhesion molecule (NCAM) provides clues to the development of testicular Leydig cells.","date":"1996","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/8792212","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18809727","id":"PMC_18809727","title":"NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18809727","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11976973","id":"PMC_11976973","title":"The role of NCAM in remyelination.","date":"2002","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/11976973","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14871854","id":"PMC_14871854","title":"Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14871854","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19246644","id":"PMC_19246644","title":"Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19246644","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10772795","id":"PMC_10772795","title":"Neural cell adhesion molecule (NCAM) and myoblast fusion.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10772795","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15965442","id":"PMC_15965442","title":"Mycosis fungoides with a CD56+ immunophenotype.","date":"2005","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15965442","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11089916","id":"PMC_11089916","title":"Control of NCAM polysialylation by the differential expression of polysialyltransferases ST8SiaII and ST8SiaIV.","date":"2000","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11089916","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32269209","id":"PMC_32269209","title":"Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p Suppresses Ameloblastoma Cell Migration.","date":"2020","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/32269209","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1856291","id":"PMC_1856291","title":"Expression of neural cell adhesion molecule (NCAM) isoforms in neuroblastoma.","date":"1991","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/1856291","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8535222","id":"PMC_8535222","title":"Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.","date":"1995","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/8535222","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17216340","id":"PMC_17216340","title":"Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.","date":"2007","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17216340","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35148379","id":"PMC_35148379","title":"NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35148379","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15883837","id":"PMC_15883837","title":"SNPs in the neural cell adhesion molecule 1 gene (NCAM1) may be associated with human neural tube defects.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15883837","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11399310","id":"PMC_11399310","title":"Genetic deletions of NCAM and PSA impair circadian function in the mouse.","date":"2001","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/11399310","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33231295","id":"PMC_33231295","title":"Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry.","date":"2020","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33231295","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7522719","id":"PMC_7522719","title":"CD56 (NCAM)-positive malignant lymphoma.","date":"1994","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/7522719","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37076499","id":"PMC_37076499","title":"Upregulation of KLK8 contributes to CUMS-induced hippocampal neuronal apoptosis by cleaving NCAM1.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37076499","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28870505","id":"PMC_28870505","title":"TGF-β1 affects cell-cell adhesion in the heart in an NCAM1-dependent mechanism.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28870505","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11174380","id":"PMC_11174380","title":"CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.","date":"2001","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11174380","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25201755","id":"PMC_25201755","title":"Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells.","date":"2014","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25201755","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24651862","id":"PMC_24651862","title":"Characterisation of genetic variation in ST8SIA2 and its interaction region in NCAM1 in patients with bipolar disorder.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24651862","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35492247","id":"PMC_35492247","title":"Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice.","date":"2022","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35492247","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25885924","id":"PMC_25885924","title":"Promotion of cell migration by neural cell adhesion molecule (NCAM) is enhanced by PSA in a polysialyltransferase-specific manner.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25885924","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27879349","id":"PMC_27879349","title":"NCAM1 Polysialylation: The Prion Protein's Elusive Reason for Being?","date":"2016","source":"ASN neuro","url":"https://pubmed.ncbi.nlm.nih.gov/27879349","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8470821","id":"PMC_8470821","title":"Expression of neural cell adhesion molecule (NCAM) during the first molar development in the mouse.","date":"1993","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/8470821","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18656513","id":"PMC_18656513","title":"Relative role of upstream regulators of Akt, ERK and CREB in NCAM- and FGF2-mediated signalling.","date":"2008","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/18656513","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8488756","id":"PMC_8488756","title":"Expression of NCAM mRNA and polypeptides in aging rat brain.","date":"1993","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8488756","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15096371","id":"PMC_15096371","title":"CD56+ lymphoma with skin involvement: clinicopathologic features and classification.","date":"2004","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15096371","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35775327","id":"PMC_35775327","title":"Human NK cells responses are enhanced by CD56 engagement.","date":"2022","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35775327","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25273375","id":"PMC_25273375","title":"NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence.","date":"2014","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25273375","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27095082","id":"PMC_27095082","title":"Pharmacological approach for targeting dysfunctional brain plasticity: Focus on neural cell adhesion molecule (NCAM).","date":"2016","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/27095082","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28076782","id":"PMC_28076782","title":"GFRα1 Regulates Purkinje Cell Migration by Counteracting NCAM Function.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28076782","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23240056","id":"PMC_23240056","title":"Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23240056","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10772769","id":"PMC_10772769","title":"CD56 directly interacts in the process of NCAM-positive target cell-killing by NK cells.","date":"2000","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/10772769","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14991542","id":"PMC_14991542","title":"Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan.","date":"2004","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14991542","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28414590","id":"PMC_28414590","title":"Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.","date":"2017","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/28414590","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34987111","id":"PMC_34987111","title":"Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease.","date":"2022","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/34987111","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3576199","id":"PMC_3576199","title":"Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing.","date":"1987","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3576199","citation_count":1087,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8493579","id":"PMC_8493579","title":"Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8493579","citation_count":772,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3281256","id":"PMC_3281256","title":"The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3281256","citation_count":758,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20696944","id":"PMC_20696944","title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20696944","citation_count":615,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20733159","id":"PMC_20733159","title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20733159","citation_count":609,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12837245","id":"PMC_12837245","title":"The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12837245","citation_count":475,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16627685","id":"PMC_16627685","title":"The phenotypes of pluripotent human hepatic progenitors.","date":"2006","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/16627685","citation_count":263,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7854457","id":"PMC_7854457","title":"Molecular characterization of eukaryotic polysialyltransferase-1.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7854457","citation_count":263,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15528382","id":"PMC_15528382","title":"CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15528382","citation_count":232,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3203385","id":"PMC_3203385","title":"Alternative splicing generates a secreted form of N-CAM in muscle and brain.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3203385","citation_count":227,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12791257","id":"PMC_12791257","title":"Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP.","date":"2003","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/12791257","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9079653","id":"PMC_9079653","title":"NCAM140 interacts with the focal adhesion kinase p125(fak) and the SRC-related tyrosine kinase p59(fyn).","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9079653","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2887295","id":"PMC_2887295","title":"Human muscle neural cell adhesion molecule (N-CAM): identification of a muscle-specific sequence in the extracellular domain.","date":"1987","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2887295","citation_count":214,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7624364","id":"PMC_7624364","title":"Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7624364","citation_count":210,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34741163","id":"PMC_34741163","title":"Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34741163","citation_count":204,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19897577","id":"PMC_19897577","title":"CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19897577","citation_count":196,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8509458","id":"PMC_8509458","title":"The fourth immunoglobulin-like domain of NCAM contains a carbohydrate recognition domain for oligomannosidic glycans implicated in association with L1 and neurite outgrowth.","date":"1993","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8509458","citation_count":192,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23365458","id":"PMC_23365458","title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23365458","citation_count":188,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10760298","id":"PMC_10760298","title":"Brain-derived neurotrophic factor restores long-term potentiation in polysialic acid-neural cell adhesion molecule-deficient hippocampus.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10760298","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28685749","id":"PMC_28685749","title":"The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28685749","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46102,"output_tokens":7218,"usd":0.123288},"stage2":{"model":"claude-opus-4-6","input_tokens":11012,"output_tokens":6139,"usd":0.312802},"total_usd":0.901269,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":59269,"output_tokens":9731,"usd":0.161886},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":13939,"output_tokens":5300,"usd":0.303293}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of the two N-terminal extracellular Ig domains of NCAM reveals a cross-shaped antiparallel dimer, providing structural basis for homophilic trans-cellular recognition and adhesion.\",\n      \"method\": \"X-ray crystallography (1.85 Å resolution)\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with direct structural validation of homophilic interaction interface\",\n      \"pmids\": [\"10802736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Polysialylation of NCAM increases intermembrane repulsion sufficient to overwhelm both homophilic NCAM and cadherin-mediated adhesion; PSA acts by steric/electrostatic repulsion in an ionic-strength-dependent manner, and PSA-NCAM:cadherin ratio determines the magnitude of adhesion attenuation.\",\n      \"method\": \"Molecular force measurements on membrane-bound NCAM; quantitative adhesion assays with controlled PSA levels\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biophysical reconstitution with quantitative force measurements and multiple controls\",\n      \"pmids\": [\"15504723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Polysialylation of NCAM is catalyzed by a single enzyme, PST-1, acting on terminal sialylation of N-glycan core structures; reconstituted in vitro using incompletely glycosylated NCAM variants and soluble recombinant polysialyltransferase.\",\n      \"method\": \"In vitro reconstitution with recombinant glycosyltransferases and NCAM glycosylation mutants\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined enzyme and substrate mutants\",\n      \"pmids\": [\"8805371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NCAM140 isoform specifically induces neurite outgrowth via homophilic receptor signaling; this requires lipid raft association of NCAM140 (mediated by palmitoylation) for activation of focal adhesion kinase and ERK1/2, and cosignaling via FGF receptor is also essential — disruption of either pathway completely blocks neurite outgrowth.\",\n      \"method\": \"Transfection of NCAM-deficient hippocampal neurons with NCAM isoforms; palmitoylation site mutagenesis; lipid raft disruption with methyl-β-cyclodextrin; specific FGFR inhibitor\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis, pharmacological inhibition, and genetic rescue in primary neurons with multiple orthogonal methods\",\n      \"pmids\": [\"11980923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Clustering of NCAM140 activates a signaling pathway involving p125FAK, p59Fyn, Ras, and MEK, leading to dual phosphorylation and activation of ERK1/2 and phosphorylation of CREB at Ser133; MAPK pathway inhibition selectively reduces NCAM-stimulated neurite outgrowth.\",\n      \"method\": \"NCAM clustering assays in neural cells; pharmacological MAPK pathway inhibition; phosphorylation assays; primary cerebellar neuron cultures\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (clustering, pharmacological inhibitors, phosphorylation assays) in neuronal cells\",\n      \"pmids\": [\"10084688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NCAM120, NCAM140, and NCAM180 form Triton X-100-insoluble complexes with βI spectrin; heteromeric spectrin (αIβI) binds directly to the intracellular domain of NCAM180; spectrin bridges PKCβ2 to NCAM140/NCAM180; NCAM activation redistributes the NCAM-spectrin-PKCβ2 complex to lipid rafts and this is required for NCAM-mediated neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation; dominant-negative βI spectrin fragment expression; lipid raft fractionation; neurite outgrowth assay in hippocampal neurons and transfected CHO cells\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, dominant-negative rescue, and functional neurite outgrowth assay with multiple controls\",\n      \"pmids\": [\"12743109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NCAM140 directly interacts with the intracellular domain of RPTPα in a Ca2+-independent manner; Ca2+-dependent spectrin cytoskeleton-mediated cross-linking enhances NCAM-RPTPα complex formation and redistributes it to lipid rafts; RPTPα is the molecular link between NCAM and p59Fyn; loss of RPTPα abolishes NCAM-mediated p59Fyn activation and blocks NCAM-dependent neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation; RPTPα-deficient mouse neurons; dominant-negative RPTPα mutants; neurite outgrowth assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding shown, genetic (KO) and dominant-negative evidence, replicated functional outcome\",\n      \"pmids\": [\"15623578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NCAM clustering at the cell surface associates NCAM with T- and L-type voltage-dependent Ca2+ channels, inducing Ca2+ influx and activation of CaMKIIα; this promotes formation of a NCAM-RPTPα-CaMKIIα complex in lipid rafts; CaMKIIα phosphorylates RPTPα at Ser180/Ser204, increasing its phosphatase activity; mutation of these sites inhibits NCAM-induced neurite outgrowth.\",\n      \"method\": \"NCAM clustering assay; calcium imaging; co-immunoprecipitation; site-directed mutagenesis of RPTPα; neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of phosphorylation sites combined with functional assays and biochemical complex formation\",\n      \"pmids\": [\"18809727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Transmembrane NCAM140 and NCAM180 are shed by a disintegrin metalloprotease (ADAM), regulated by ERK1/2 MAP kinase; metalloprotease inhibition increases NCAM-dependent neurite branching and outgrowth; transgenic mouse model of NCAM shedding shows reduced neurite outgrowth and branching, demonstrating that ectodomain shedding down-regulates neuronal connectivity.\",\n      \"method\": \"Metalloprotease inhibition (GM6001); pervanadate-induced shedding; transgenic NCAM-shedding mouse model; neurite outgrowth and branching assays in cortical neurons\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition and transgenic in vivo model with defined functional phenotype\",\n      \"pmids\": [\"16967505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Neuronal membrane depolarization triggers skipping of NCAM exon 18 by inducing H3K9 hyperacetylation restricted to the intragenic region surrounding the alternative exon; this chromatin change is linked to H3K36 trimethylation and results from altered RNA Pol II elongation rate; effects are reversible and independent of CaMKIV pathway.\",\n      \"method\": \"Neuronal depolarization; chromatin immunoprecipitation (ChIP) for H3K9ac and H3K36me3; slow Pol II mutant; HDAC inhibitor (trichostatin A); RT-PCR for splicing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (ChIP, mutant Pol II, pharmacological) linking intragenic epigenetic changes to splicing outcome\",\n      \"pmids\": [\"19251664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"During neuronal differentiation, increases in repressive intragenic chromatin marks H3K9me2 and H3K27me3 correlate with inhibition of Pol II elongation at the NCAM exon 18 region and promote exon 18 inclusion; intronic siRNA targeting NCAM intron 18 induces these repressive marks and is sufficient to promote exon 18 inclusion in undifferentiated cells.\",\n      \"method\": \"ChIP; pharmacological inhibitors (5-azacytidine, BIX01294); intronic siRNA; Pol II elongation analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal approaches including causal intronic siRNA experiment and chemical inhibitors replicate the chromatin-splicing link\",\n      \"pmids\": [\"23892457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Expression of transmembrane NCAM-B (but not GPI-linked NCAM-C) in NCAM-negative glioma cells down-regulates secretion of MMP-9 (92-kDa gelatinase) and MMP-1 (interstitial collagenase), demonstrating isoform-specific regulation of extracellular matrix metalloproteinase secretion by NCAM.\",\n      \"method\": \"Transfection of NCAM isoforms into NCAM-negative glioma cells; metalloproteinase activity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct transfection experiment with isoform comparison, single lab\",\n      \"pmids\": [\"8265575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Insertion of the VASE sequence (10 amino acids) into the fourth Ig domain of NCAM specifically inhibits NCAM-induced neurite outgrowth; a synthetic VASE peptide inhibits NCAM-stimulated neurite outgrowth from PC12 cells and primary neurons without affecting integrin-, N-cadherin-, or L1-dependent outgrowth; VASE may act by preventing NCAM binding to the FGF receptor.\",\n      \"method\": \"PC12 cell transfection with NCAM isoforms ± VASE; synthetic VASE peptide inhibition assay; selectivity controls with other adhesion molecules\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional transfection and peptide inhibition with isoform specificity controls, single lab\",\n      \"pmids\": [\"8163558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Mouse myoblasts transfected to constitutively express the human muscle-specific 125 kDa GPI-linked NCAM isoform more readily fuse to form myotubes, indicating NCAM promotes myoblast fusion and the isoform switch from 145 kDa transmembrane to 125 kDa GPI-linked form during myogenesis may facilitate this function.\",\n      \"method\": \"Stable transfection of myoblasts with human NCAM isoform; myoblast fusion/myotube formation assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function transfection with functional fusion readout, single study\",\n      \"pmids\": [\"2179732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"In NCAM-null mice, fasciculation and pathfinding of hippocampal mossy fiber axons are severely disrupted, and the phenotype is more severe in adults than young animals, demonstrating an essential role for NCAM in axonal growth, fasciculation, and maintenance of plasticity in the mature nervous system.\",\n      \"method\": \"NCAM gene-targeted knockout mouse; histological and immunohistochemical analysis of mossy fiber tract\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complete genetic loss-of-function in vivo with specific anatomical and developmental phenotype\",\n      \"pmids\": [\"9073395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAP-43 potentiates NCAM-induced neurite outgrowth via a membrane association-dependent mechanism; in the presence of GAP-43, NCAM-180/spectrin/GAP-43 interaction is the predominant pathway, while in its absence NCAM-140/Fyn pathway predominates; GAP-43 phosphorylation by PKC and CKII is required for NCAM-induced neurite outgrowth.\",\n      \"method\": \"Overexpression in PC12E2 cells and hippocampal neurons; dominant-negative constructs; kinase inhibitors; neurite outgrowth assay\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and overexpression constructs with functional assay, single lab\",\n      \"pmids\": [\"17212696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ST8SiaII and ST8SiaIV polysialyltransferases both act on N-glycosylation sites 5 and 6 of NCAM in vivo; ST8SiaIV is the major regulator of NCAM polysialylation, producing shorter PSA chains, while ST8SiaII promotes longer chains; the two enzymes act synergistically at site 5 to generate long PSA chains.\",\n      \"method\": \"ST8SiaII- and ST8SiaIV-deficient mouse brains; isolation of PSA-NCAM; glycopeptide and glycan analysis by mass spectrometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo enzyme-deficient mouse models with detailed mass spectrometric structural analysis\",\n      \"pmids\": [\"17986444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NCAM promotes ovarian cancer cell migration and invasion in vitro and metastatic dissemination in mice via interaction with FGF receptor (FGFR); FGFR signaling is required for NCAM-induced cell motility; a monoclonal antibody targeting the NCAM/FGFR interplay abolishes metastatic dissemination in vivo.\",\n      \"method\": \"In vitro migration/invasion assays; mouse metastasis model; FGFR inhibition; anti-NCAM/FGFR monoclonal antibody\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo functional assays with pharmacological and antibody-based pathway validation\",\n      \"pmids\": [\"21739604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NCAM1 promotes leukemic cell survival and stress resistance by constitutively activating the MAPK pathway; genetic depletion of NCAM1 induces apoptosis/differentiation and sensitizes AML cells to genotoxic agents in vitro and in vivo; MEK1/2 inhibition specifically inhibits proliferation and sensitizes NCAM1+ AML cells to chemotherapy.\",\n      \"method\": \"Genetic knockdown/knockout of NCAM1 in AML cell lines; murine leukemia model with serial transplantation; phosphoproteomics; MEK1/2 pharmacological inhibition\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary genetic strategies plus phosphoproteomics plus in vivo mouse model with defined mechanistic pathway\",\n      \"pmids\": [\"30814062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM1 functions as a receptor for Zika virus entry into host cells; overexpression of NCAM1 increases ZIKV infection, while knockout or inhibition of NCAM1 reduces it in Vero and human glioblastoma cells.\",\n      \"method\": \"Chemical proteomics with photocrosslinking probe; NCAM1 overexpression and knockout in Vero and U-251 MG cells; mass spectrometry identification\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chemical proteomic identification with genetic overexpression and KO validation, single lab\",\n      \"pmids\": [\"32753727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD56 (NCAM1) regulates human NK cell cytotoxicity by promoting lytic granule exocytosis and immunological synapse polarization; CD56 KO in NK92 cells impairs cytotoxicity and reduces Pyk2 phosphorylation at Tyr402; reintroduction of CD56 rescues cytotoxicity, granule exocytosis, and Pyk2 phosphorylation, demonstrating a functional link between CD56 and Pyk2 (FAK family) signaling.\",\n      \"method\": \"CRISPR/Cas9 knockout of CD56 in NK92; rescue by CD56 reintroduction; lytic granule exocytosis assay; immunological synapse imaging; phospho-Pyk2 western blot\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with rescue, multiple functional readouts and defined signaling mechanism\",\n      \"pmids\": [\"32510326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Anti-NCAM1 autoantibodies from schizophrenia patients disrupt NCAM1-NCAM1 homophilic interactions and NCAM1-GDNF binding; introduction into mouse CSF interrupts NCAM1-Fyn interaction, inhibits FAK, MEK1, and ERK1 phosphorylation, reduces dendritic spine and synapse number in frontal cortex, and induces schizophrenia-related behaviors.\",\n      \"method\": \"Cell-based assay and ELISA for autoantibodies; binding/interaction assays; intracerebroventricular antibody injection in mice; spine/synapse imaging; behavioral testing; phosphoprotein analysis\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived antibodies with in vivo functional validation and multiple mechanistic readouts\",\n      \"pmids\": [\"35492247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLK8 (tissue kallikrein-related peptidase 8) proteolytically cleaves the NCAM1 extracellular domain; KLK8 upregulation in CUMS mouse hippocampus causes NCAM1 loss and promotes neuronal apoptosis; NCAM1 overexpression or NCAM1 mimetic peptide rescues KLK8-overexpression-induced apoptosis.\",\n      \"method\": \"Transgenic KLK8 overexpression and KLK8-knockout mice; adenovirus-mediated NCAM1 overexpression; co-immunoprecipitation; immunofluorescence; apoptosis assays in HT22 cells and primary neurons\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic and in vitro biochemical evidence for cleavage with functional rescue, single lab\",\n      \"pmids\": [\"37076499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TGFβ1 induces NCAM1 expression in cardiomyocytes via a p38-dependent pathway; NCAM1 upregulation mediates TGFβ1-induced alterations in intercalated disc structure and cell-cell adhesion in ventricular myocytes; selective knockdown of NCAM1 rescues the TGFβ1-induced cell adhesion defect.\",\n      \"method\": \"Cardiac-specific TGFβ1 transgenic mice; electron microscopy; immunostaining; NCAM1 knockdown; p38 inhibition\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic mouse model with rescue experiment and pathway inhibition, single lab\",\n      \"pmids\": [\"28870505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GFRα1 directly interacts with NCAM in embryonic Purkinje cells; NCAM restricts Purkinje cell migration; GFRα1 counteracts NCAM function (both in cis and trans) to promote Purkinje cell migration; genetic reduction of NCAM restores migration in Gfra1 mutant mice.\",\n      \"method\": \"GFRα1 knockout and NCAM genetic reduction mouse models; direct interaction assay; epistasis by double-mutant analysis; in vitro migration assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double-mutant rescue, direct protein interaction, and in vitro functional assays\",\n      \"pmids\": [\"28076782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Peripheral nerve injury increases turnover of NCAM1 in synapses of the anterior cingulate cortex (ACC); NCAM1 mediates spine reorganization in the ACC and contributes to behavioral sensitization (neuropathic pain); the mechanism parallels NMDA receptor- and protein synthesis-dependent LTP maintenance.\",\n      \"method\": \"Peripheral nerve injury mouse model; synaptic protein turnover assay; ACC-specific NCAM1 manipulation; spine imaging; behavioral pain sensitization assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function with spine and behavioral phenotype, single lab\",\n      \"pmids\": [\"29346771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Loss of PSA (but not NCAM itself) in NCAM(tm1Cwr) mice disrupts free-running circadian rhythmicity under constant darkness; loss of all NCAM isoforms (NCAM(tm1Cgn)) additionally impairs entrainment to light-dark cycles; when NCAM180 is deleted, NCAM140 compensates as PSA carrier in the SCN, indicating PSA carried by NCAM is required for circadian function.\",\n      \"method\": \"Three NCAM/PSA transgenic mutant mouse strains; locomotor activity monitoring under LD and DD conditions\",\n      \"journal\": \"Physiology & behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with multiple alleles distinguishing NCAM vs PSA contributions, single lab\",\n      \"pmids\": [\"11399310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NCAM-mediated ERK phosphorylation requires FGFR, Src-family kinases, MEK, and G0/Gi-proteins; NCAM-mediated Akt phosphorylation requires cGMP and PI3K; NCAM-mediated CREB phosphorylation requires Src-family kinases and MEK, but all three are independent of PLC, PKC, PKA, and CaMKII, delineating the hierarchical signaling network downstream of NCAM.\",\n      \"method\": \"Pharmacological inhibitors of specific kinases/signaling molecules; phosphorylation assays in rat cerebellar granule neurons stimulated with NCAM ligand (C3d peptide)\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic pharmacological dissection with multiple inhibitors in primary neurons, single lab\",\n      \"pmids\": [\"18656513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A monoclonal antibody (HR1) targeting the region C-terminal to the fifth Ig domain of NCAM (the hinge region, 15 amino acids immediately C-terminal to Ig5) disrupts axonal fasciculation, orientation, and pathfinding in retina organ culture, demonstrating this region is required for NCAM function on growing axons; PSA chains on Ig5 normally mask this region.\",\n      \"method\": \"Retina organ culture; monoclonal antibody application; peptide epitope mapping; neuraminidase treatment to remove PSA\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antibody perturbation in organ culture with structural epitope mapping, single lab\",\n      \"pmids\": [\"8462735\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NCAM1 (CD56) is a multifunctional Ig-superfamily cell adhesion molecule that mediates homophilic trans-adhesion through antiparallel Ig-domain dimers; its major isoforms (NCAM120-GPI, NCAM140-transmembrane, NCAM180-transmembrane) signal via lipid-raft-associated palmitoylation of NCAM140, recruitment of RPTPα (which activates p59Fyn), spectrin-bridged PKCβ2 complexes, and CaMKIIα, converging on FAK/Pyk2, Ras–MEK–ERK, and PI3K–Akt to drive neurite outgrowth, synapse remodeling, and cell migration; polysialylation of NCAM (catalyzed by ST8SIA2/ST8SIA4 on N-glycosylation sites 5 and 6) sterically and electrostatically abrogates adhesion to tune cell-cell interactions; NCAM ectodomain shedding by ADAM metalloproteases down-regulates neuronal connectivity; intragenic H3K9 acetylation/methylation couples neuronal activity and differentiation state to NCAM exon 18 alternative splicing via RNA Pol II elongation kinetics; and in NK cells, CD56 drives lytic granule exocytosis and cytotoxicity through Pyk2 phosphorylation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"NCAM is a member of the immunoglobulin superfamily with five contiguous Ig-like domains in its extracellular region. Three major polypeptide isoforms (120, 140, 180 kDa) share an identical extracellular region but differ in their membrane-associated and cytoplasmic domains through alternative RNA splicing. Homophilic binding is mediated by interactions among the Ig-like domains, and regulation is achieved not by changes in binding-site sequence but by cell surface modulation events (PSA content, prevalence, mobility) and alternative splicing that alter isoform-specific cytoplasmic interactions.\",\n      \"method\": \"cDNA cloning, amino acid sequencing of CNBr/proteolytic fragments, Northern blot\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational structural paper with complete sequence determination and multiple orthogonal methods; >1000 citations\",\n      \"pmids\": [\"3576199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"A muscle-specific sequence domain (MSD1) of 37 amino acids is present in the extracellular region of the 5.2 and 4.3 kb NCAM isoforms expressed during myotube formation but absent from transmembrane isoforms in myoblasts and from brain NCAM, demonstrating tissue-specific alternative splicing within the extracellular domain.\",\n      \"method\": \"cDNA cloning, Northern blot, sequencing\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing of multiple cDNA isoforms with tissue-expression validation; >200 citations\",\n      \"pmids\": [\"2887295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"A secreted isoform of NCAM is generated by alternative splicing that inserts a novel exon into the extracellular domain, introducing an in-frame stop codon; stable transfectants expressing this isoform accumulate it intracellularly and secrete it into the medium, contrasting with GPI-anchored NCAM that is expressed at the cell surface.\",\n      \"method\": \"cDNA cloning, genomic analysis, stable transfection, immunoprecipitation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted secretion in transfectants with molecular characterization; >200 citations\",\n      \"pmids\": [\"3203385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"NCAM regulates membrane-membrane contact required for diverse intercellular events. When NCAM carries low polysialic acid (PSA), adhesion is increased and contact-dependent signaling is triggered; when PSA content is high, the large excluded volume of PSA sterically inhibits membrane apposition and cell-cell interactions.\",\n      \"method\": \"Cell adhesion assays, enzymatic PSA removal, antibody blocking\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays establishing PSA-mediated steric hindrance mechanism; >750 citations\",\n      \"pmids\": [\"3281256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Mouse myoblasts transfected to constitutively express the human muscle-specific 125 kDa GPI-linked NCAM isoform fuse more readily to form myotubes than controls, demonstrating that NCAM promotes myoblast fusion and that the isoform switch (transmembrane to GPI-linked) may promote this function.\",\n      \"method\": \"Stable transfection of myoblasts, fusion assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function transfection with specific isoform and quantitative fusion readout; >100 citations\",\n      \"pmids\": [\"2179732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The fourth Ig-like domain of NCAM contains a carbohydrate recognition domain (with sequence homology to C-type lectins) that mediates binding to oligomannosidic glycans on L1, forming a heterophilic cis-complex. A peptide from this domain disrupts L1-NCAM association and inhibits neurite outgrowth, demonstrating that carbohydrate-mediated cis-association between L1 and NCAM modulates their functional properties.\",\n      \"method\": \"Co-immunoprecipitation, carbohydrate inhibition assays, recombinant domain binding, peptide inhibition, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (co-IP, recombinant fragments, peptides, functional neurite assay); >190 citations\",\n      \"pmids\": [\"8509458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Expression of the transmembrane NCAM-B isoform (but not GPI-linked NCAM-C) in NCAM-negative rat glioma cells induces down-regulation of 92-kDa gelatinase (MMP-9) and interstitial collagenase (MMP-1) secretion, indicating that transmembrane NCAM signaling regulates extracellular matrix metalloproteinase production.\",\n      \"method\": \"Transfection of NCAM isoforms into glioma cells, metalloproteinase zymography/activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific transfection with direct MMP activity measurement; replicated with two isoforms as controls\",\n      \"pmids\": [\"8265575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The VASE exon (10 amino acids inserted into the fourth Ig domain) in NCAM receptors specifically inhibits NCAM-stimulated neurite outgrowth. Both the 140- and 180-kDa isoforms without VASE are functional receptors for neurite outgrowth; a VASE-containing peptide inhibits NCAM-dependent but not integrin-, N-cadherin-, or L1-dependent neurite outgrowth, suggesting that VASE prevents NCAM from engaging the FGF receptor.\",\n      \"method\": \"PC12 transfection with NCAM isoforms ± VASE, synthetic peptide inhibition, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean isoform-specific transfection, peptide specificity controls, multiple neuronal substrates tested\",\n      \"pmids\": [\"8163558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Polysialylation of NCAM is catalyzed by a single enzyme, PST-1 (polysialyltransferase-1), as demonstrated by reconstitution of PSA synthesis on incompletely glycosylated NCAM variants in vitro using soluble recombinant enzyme. Terminal sialylation of the N-glycan core is sufficient to generate the PSA acceptor site.\",\n      \"method\": \"In vitro reconstitution with recombinant PST-1, incompletely glycosylated NCAM variants\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic reconstitution with defined substrates\",\n      \"pmids\": [\"8805371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Molecular cloning of eukaryotic polysialyltransferase-1 (PST-1) and demonstration that expression of this single enzyme is sufficient to induce PSA synthesis on all NCAM-expressing cell lines in reconstitution experiments, establishing that polycondensation of α-2,8-linked sialic acids on NCAM is the result of a single enzymatic activity.\",\n      \"method\": \"Expression cloning, transfection, reconstitution in NCAM-expressing cell lines\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution experiment with cloned enzyme; >260 citations\",\n      \"pmids\": [\"7854457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Expression cloning of a human polysialyltransferase (ST8SIA2/STX) that forms polysialylated NCAM present in embryonic brain. HeLa cells stably expressing polysialic acid and NCAM promoted neurite outgrowth and sprouting, indicating that polysialylated NCAM is critical for neural plasticity.\",\n      \"method\": \"Expression cloning, FACS sorting, stable transfection, neurite outgrowth assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — expression cloning with functional validation; >200 citations\",\n      \"pmids\": [\"7624364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NCAM140 selectively co-immunoprecipitates with p59(fyn) from neonatal mouse cerebellum and transfected cells (NCAM180 and NCAM120 do not). NCAM activation (via antibody clustering or soluble NCAM fusion protein) recruits p125(fak) to the NCAM140-p59(fyn) complex and induces rapid transient tyrosine phosphorylation (activation) of both kinases, initiating a signaling cascade linked to growth cone migration.\",\n      \"method\": \"Co-immunoprecipitation from brain tissue and transfected cells, tyrosine phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP in native brain and transfected cells; isoform specificity demonstrated; >200 citations\",\n      \"pmids\": [\"9079653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NCAM-deficient mice show severely impaired fasciculation and pathfinding of hippocampal mossy fiber axons, with alterations in mossy fiber terminal distribution, demonstrating that NCAM is essential for axonal growth, fasciculation, and maintenance of plasticity in the mature nervous system.\",\n      \"method\": \"Analysis of NCAM knockout mice (all isoforms), histology, axon tract tracing\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined anatomical phenotype; >240 citations\",\n      \"pmids\": [\"9073395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Clustering of the NCAM140 isoform stimulates activation (dual phosphorylation) of ERK1/2 through a pathway involving p125fak, p59fyn, Ras, and MEK, and also induces phosphorylation of CREB at Ser133. Inhibition of the MAPK pathway selectively reduces NCAM-stimulated neurite outgrowth in cerebellar neurons.\",\n      \"method\": \"NCAM antibody clustering, kinase phosphorylation assays, specific pathway inhibitors, cerebellar neuron culture neurite outgrowth assay\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway dissection with multiple specific inhibitors and functional readout; >190 citations\",\n      \"pmids\": [\"10084688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure (1.85 Å) of the two N-terminal extracellular Ig-like domains of NCAM reveals a cross-shaped antiparallel dimer in molecular packing, providing the structural basis for homophilic trans-cellular recognition: NCAM forms cis-dimers that mediate low-affinity trans-interactions between cells in zipper-like arrays.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — 1.85 Å crystal structure with functional implication; >100 citations\",\n      \"pmids\": [\"10802736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NCAM functions as a signaling receptor for GDNF family ligands independent of RET. NCAM associates with GFRα1 (GPI-anchored GDNF receptor), enabling high-affinity GDNF binding to p140(NCAM) and rapid activation of cytoplasmic kinases Fyn and FAK in RET-deficient cells. GDNF stimulates Schwann cell migration and hippocampal/cortical axonal growth via NCAM-Fyn activation.\",\n      \"method\": \"Co-immunoprecipitation, binding assays, kinase activation assays in RET-null cells, migration assay, neurite outgrowth assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in RET-deficient cells establishing a new signaling pathway; >475 citations\",\n      \"pmids\": [\"12837245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Lipid raft association of NCAM140 is required for activation of the non-receptor tyrosine kinase pathway and neurite outgrowth. Mutation of NCAM140 palmitoylation sites or destruction of lipid rafts attenuates activation of FAK and ERK1/2, completely blocking neurite outgrowth. Cosignaling via both raft-associated kinases and the FGF receptor is essential for neuritogenesis.\",\n      \"method\": \"Hippocampal neuron transfection in NCAM-null mice, palmitoylation-site mutagenesis, methyl-β-cyclodextrin raft disruption, FGFR inhibitor, phospho-kinase assays, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis, pharmacological raft disruption, and specific FGFR inhibitor in NCAM-null background; >225 citations\",\n      \"pmids\": [\"11980923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NCAM (120, 140, 180 isoforms) forms Triton X-100-insoluble complexes with βI spectrin in hippocampal neurons. βI spectrin binds directly to the intracellular domain of NCAM180 (and via lipid rafts to NCAM120). PKCβ2 forms complexes with NCAM140/NCAM180 and spectrin; NCAM activation enhances this complex and redistributes it to lipid rafts via FGFR. Dominant-negative βI spectrin fragment disrupts the complex and inhibits NCAM-induced neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation, lipid raft fractionation, dominant-negative transfection, FGFR inhibitor, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, biochemical fractionation, and dominant-negative rescue with functional readout; >110 citations\",\n      \"pmids\": [\"12743109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Direct interaction between NCAM fibronectin type III modules 1 and 2 and FGFR1 Ig modules 2 and 3 demonstrated by surface plasmon resonance. NMR structure of NCAM F3 module 2 shows overlapping binding sites for FGFR1 and ATP; ATP inhibits the NCAM-FGFR interaction and inhibits NCAM-induced neurite outgrowth, revealing ATP as a molecular switch regulating NCAM-FGFR signaling.\",\n      \"method\": \"Surface plasmon resonance, NMR structure determination, FGFR phosphorylation assay, neurite outgrowth assay\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure + SPR binding + functional validation; >220 citations\",\n      \"pmids\": [\"12791257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NCAM polysialylation increases intermembrane repulsion quantitatively by steric/ionic mechanisms, overwhelming both homophilic NCAM and cadherin-mediated attraction at physiological ionic strength. The repulsion is ionic-strength dependent and PSA-dose dependent, revealing the molecular mechanism by which PSA-NCAM regulates cell adhesion.\",\n      \"method\": \"Molecular force measurements (surface force apparatus) on membrane-bound NCAM\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical reconstitution with cadherin controls; >180 citations\",\n      \"pmids\": [\"15504723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NCAM140 directly interacts with the intracellular domain of RPTPα, a known activator of p59fyn. NCAM activation promotes Ca2+-dependent spectrin-mediated crosslinking of NCAM and RPTPα and redistributes the complex to lipid rafts. RPTPα-deficient neurons lose NCAM-p59fyn association and NCAM-mediated p59fyn activation, blocking NCAM-dependent neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation, RPTPα-knockout neurons, dominant-negative RPTPα, lipid raft fractionation, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic (KO), biochemical (co-IP), and dominant-negative approaches converge on same phenotype; >95 citations\",\n      \"pmids\": [\"15623578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Metalloprotease-induced ectodomain shedding of NCAM140 releases a 115-kDa soluble fragment. Shedding is induced by the tyrosine phosphatase inhibitor pervanadate via an ADAM metalloprotease regulated by ERK1/2. Metalloprotease inhibitor GM6001 increases NCAM-dependent neurite branching and outgrowth; a transgenic NCAM-shedding mouse model shows impaired neuronal connectivity.\",\n      \"method\": \"NCAM transfection in L-fibroblasts, pharmacological inhibitors, metalloprotease inhibitors, transgenic mouse model, neurite outgrowth assay\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection and transgenic model with functional readout; >90 citations\",\n      \"pmids\": [\"16967505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ST8SiaIV is the major regulator of NCAM polysialylation in vivo. Analysis of mice lacking ST8SiaII or ST8SiaIV shows that both enzymes polysialylate N-glycosylation sites 5 and 6 of NCAM with the same glycan sets, but ST8SiaII and ST8SiaIV act synergistically to produce long polySia chains at site 5; ST8SiaIV alone yields shorter chains.\",\n      \"method\": \"Analysis of polysialyltransferase knockout mice, glycopeptide mass spectrometry, polySia chain-length analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo genetic models with detailed glycan structure analysis\",\n      \"pmids\": [\"17986444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NCAM clustering at the cell surface is coupled to Ca2+ influx via T- and L-type voltage-dependent Ca2+ channels associated with NCAM, activation of CaMKIIα, and serine phosphorylation of RPTPα at Ser180 and Ser204, increasing RPTPα phosphatase activity. Mutation of these serine residues interferes with NCAM-induced neurite outgrowth, establishing a novel NCAM→Ca2+ channel→CaMKIIα→RPTPα→neurite outgrowth cascade.\",\n      \"method\": \"NCAM clustering assay, Ca2+ channel co-IP, CaMKIIα activation assay, RPTPα serine phosphorylation, dominant-negative/mutant transfection, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic cascade identified through co-IP, pharmacology, mutagenesis, and functional readout\",\n      \"pmids\": [\"18809727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GAP-43 phosphorylation by PKC or CKII potentiates NCAM-180/spectrin-mediated neurite outgrowth. In the presence of GAP-43, NCAM-180/spectrin/GAP-43 association is required; in its absence, the NCAM-140/Fyn pathway dominates. GAP-43 thus acts as a molecular switch that determines the predominant NCAM signaling mechanism.\",\n      \"method\": \"GAP-43 overexpression, phosphorylation mutants, dominant-negative betaI spectrin, neurite outgrowth assay in PC12 and hippocampal neurons\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutant constructs and functional readout, single laboratory\",\n      \"pmids\": [\"17212696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NCAM-mediated ERK phosphorylation requires FGFR, Src-family kinases, MEK, and Gi/G0-proteins; NCAM-mediated CREB phosphorylation requires Src-family kinases and MEK; NCAM-mediated Akt phosphorylation requires cGMP and PI3K. These pathways are independent of PLC, PKC, PKA, and CaMKII, revealing a specific signaling hierarchy downstream of NCAM.\",\n      \"method\": \"NCAM ligand (C3d peptide) stimulation of cerebellar granule neurons, specific pathway inhibitors, phospho-kinase assays\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic pharmacological pathway dissection; single laboratory\",\n      \"pmids\": [\"18656513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Neuronal membrane depolarization triggers skipping of NCAM exon 18, independently of the CaMKIV pathway. This splicing change is regulated by RNA Pol II elongation rate and is accompanied by H3K9 hyper-acetylation restricted to the intragenic region surrounding exon 18, without promoter acetylation changes; effects are reversible and potentiated by HDAC inhibitor TSA.\",\n      \"method\": \"Neuronal depolarization, RT-PCR splicing assay, slow Pol II mutant, ChIP for H3K9ac and H3K36me3, HDAC inhibitor\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (slow polymerase mutant, ChIP, pharmacological) establishing mechanism; >220 citations\",\n      \"pmids\": [\"19251664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NCAM promotes ovarian cancer cell migration and peritoneal metastasis via direct interaction with FGFR. FGFR signaling is required for NCAM-induced cell motility, and a monoclonal antibody targeting the NCAM/FGFR interplay abolishes metastatic dissemination in mice.\",\n      \"method\": \"In vitro migration/invasion assays, FGFR inhibition, anti-NCAM monoclonal antibody, mouse peritoneal metastasis model\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo validation with antibody blockade; >65 citations\",\n      \"pmids\": [\"21739604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Intragenic repressive chromatin marks (H3K9me2, H3K27me3) increase along the NCAM gene body during neuronal differentiation, correlating with inhibition of Pol II elongation in the exon 18 region and increased exon 18 inclusion. Intronic siRNAs targeting NCAM intron 18 induce H3K9me2 and promote E18 inclusion in undifferentiated cells, confirming that intragenic chromatin deployment is sufficient to alter NCAM alternative splicing.\",\n      \"method\": \"ChIP for H3K9me2/H3K27me3, 5-azacytidine and BIX01294 inhibition, intronic siRNA-directed chromatin changes, RT-PCR splicing assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — pharmacological, siRNA-epigenetic, and ChIP approaches converge; >75 citations\",\n      \"pmids\": [\"23892457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NeuroD1 transcriptionally regulates NCAM expression in neuroendocrine lung carcinomas; impaired NeuroD1 expression mirrors loss of NCAM, and NCAM is a downstream target of NeuroD1 that promotes tumor cell survival and metastasis.\",\n      \"method\": \"NeuroD1 knockdown/overexpression, gene expression analysis, cell survival and migration assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic perturbation with functional readouts, single laboratory\",\n      \"pmids\": [\"23553831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GFRα1 directly interacts with NCAM in embryonic Purkinje cells. Genetic reduction of NCAM expression enhances wild-type Purkinje cell migration and rescues delayed migration in Gfra1 mutants, demonstrating that NCAM restricts Purkinje cell migration and that GFRα1 promotes migration by limiting NCAM function in cis and trans.\",\n      \"method\": \"Co-immunoprecipitation, Gfra1/NCAM genetic mutants, in vitro migration assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (double mutant rescue) plus co-IP and in vitro functional assay\",\n      \"pmids\": [\"28076782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TGFβ1 induces NCAM1 expression in cardiomyocytes via a p38-dependent pathway; selective targeting of NCAM1 rescues the cell-cell adhesion defect caused by TGFβ1. NCAM1 protein levels correlate with TGFβ1 activity in human cardiomyopathy samples.\",\n      \"method\": \"Cardiac-specific TGFβ1 transgenic mice, electron microscopy, p38 inhibition, NCAM1 siRNA, immunostaining\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model plus pharmacological and siRNA interventions with functional rescue\",\n      \"pmids\": [\"28870505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Peripheral nerve injury activates the anterior cingulate cortex (ACC) and increases turnover of NCAM1 at synapses. NCAM1 mediates dendritic spine reorganization in the ACC and contributes to behavioral sensitization after nerve injury through a mechanism parallel to NMDA-receptor- and protein-synthesis-dependent LTP.\",\n      \"method\": \"Peripheral nerve injury model, synaptic protein turnover analysis, spine morphology, behavioral assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined synaptic and behavioral phenotype, single laboratory\",\n      \"pmids\": [\"29346771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NCAM1 regulates AML cell survival and stress resistance. Loss of NCAM1 induces cell death or differentiation and sensitizes blasts to genotoxic agents. NCAM1 expression is associated with constitutive activation of the MAPK pathway; MEK1/2 inhibition specifically sensitizes NCAM1+ AML cells to chemotherapy. Depletion of Ncam1 in a murine leukemia model reduced leukemia-initiating cells and prolonged disease latency.\",\n      \"method\": \"Genetic knockdown/knockout (NCAM1), phosphoproteomics, transcriptomics, in vitro cytotoxicity assays, murine transplantation model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary genetic strategies, phosphoproteomics, and in vivo murine leukemia model\",\n      \"pmids\": [\"30814062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM1 functions as a receptor for Zika virus (ZIKV) entry. Chemical proteomic photocrosslinking identified NCAM1 as a ZIKV-interacting protein; overexpression of NCAM1 enhanced ZIKV infection while knockout and inhibition reduced it in Vero and U-251 MG cells.\",\n      \"method\": \"Chemical proteomics (photocrosslinking + biotin enrichment + MS), NCAM1 overexpression, knockout, and inhibition, infection assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — discovery by chemical proteomics validated by gain- and loss-of-function in two cell lines\",\n      \"pmids\": [\"32753727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD56 (NCAM1) deletion in NK92 cells impairs cytotoxic function, lytic granule exocytosis, and immunological synapse polarization. Phosphorylation of the FAK family member Pyk2 at Tyr402 is decreased in CD56-KO cells; reintroduction of CD56 rescues cytotoxicity, exocytosis, and Pyk2 phosphorylation, establishing a functional link between NCAM1 and Pyk2 signaling in NK cell cytotoxicity.\",\n      \"method\": \"CRISPR-Cas9 knockout of CD56 in NK92, lytic granule exocytosis assay, immunological synapse assay, phospho-Pyk2 immunoblot, CD56 rescue transfection\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with genetic rescue and multiple functional readouts\",\n      \"pmids\": [\"32510326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Anti-NCAM1 autoantibodies from schizophrenia patients disrupt NCAM1-NCAM1 homophilic binding, NCAM1-GDNF, and NCAM1-Fyn interactions. Intracerebrospinal introduction into mice inhibits FAK, MEK1, and ERK1 phosphorylation, reduces spine and synapse number in frontal cortex, and induces schizophrenia-related behavior (deficient pre-pulse inhibition, cognitive impairment).\",\n      \"method\": \"Cell-based autoantibody assay, ELISA, in vitro interaction blocking assays, intrathecal antibody injection in mice, immunofluorescence (spine/synapse density), behavioral assays\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived antibody with defined molecular targets and in vivo behavioral validation\",\n      \"pmids\": [\"35492247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLK8 (a serine protease) proteolytically cleaves the extracellular domain of NCAM1 in hippocampal neurons, decreasing NCAM1 surface expression. Transgenic KLK8 overexpression exacerbates CUMS-induced hippocampal neuronal apoptosis and depression-like behavior; KLK8 deficiency prevents NCAM1 loss. Both NCAM1 overexpression and an NCAM1 mimetic peptide rescue KLK8-overexpressing neurons from apoptosis.\",\n      \"method\": \"KLK8 transgenic and KO mice, CUMS model, adenoviral NCAM1 overexpression, co-immunoprecipitation, protease cleavage assay, NCAM1 mimetic peptide rescue, immunofluorescence\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic gain- and loss-of-function, biochemical cleavage assay, and functional rescue\",\n      \"pmids\": [\"37076499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PSA-NCAM directly interacts with BDNF. Enzymatic removal of PSA (Endo-N) or NCAM knockout reduces LTP in hippocampal CA1 and reduces TrkB phosphorylation. Exogenous BDNF restores deficient LTP in both NCAM-KO and Endo-N-treated slices, suggesting that PSA-NCAM sensitizes pyramidal neurons to BDNF to modulate activity-dependent synaptic plasticity.\",\n      \"method\": \"NCAM knockout mice, Endo-N enzymatic PSA removal, organotypic hippocampal slice LTP recordings, BDNF rescue, TrkB phosphorylation assay, PSA-NCAM binding to BDNF\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO and enzymatic ablation converge; BDNF rescue and TrkB phosphorylation data; >175 citations\",\n      \"pmids\": [\"10760298\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NCAM1 is a multifunctional immunoglobulin-superfamily cell adhesion molecule that mediates homophilic cell-cell adhesion through cis-dimerization and zipper-like trans-interactions of its five Ig-like extracellular domains, with adhesion strength controlled by polysialylation (via ST8SIA2/ST8SIA4) that exerts steric/ionic repulsion; upon homophilic or heterophilic engagement, the NCAM140 isoform—whose raft association depends on palmitoylation—recruits RPTPα, which activates p59(fyn) and p125(FAK), triggering the Ras→MEK→ERK1/2 cascade and CREB phosphorylation to drive neurite outgrowth, while additionally serving as a co-receptor for GDNF via GFRα1 (activating Fyn/FAK independently of RET), interacting directly with FGFR1 through its fibronectin type III modules (regulated by ATP), being subject to ADAM metalloprotease ectodomain shedding regulated by ERK, and undergoing activity-dependent alternative splicing through intragenic epigenetic changes; in NK cells NCAM1 engages Pyk2 to promote lytic granule exocytosis, and in AML it sustains leukemic stem cell survival via constitutive MAPK activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NCAM1 (CD56) is an immunoglobulin-superfamily cell adhesion molecule that mediates homophilic trans-cellular recognition, intracellular signaling, and context-dependent regulation of cell–cell interactions across neural development, immune function, and disease. Its N-terminal Ig domains form antiparallel dimers that constitute the structural basis for homophilic adhesion [PMID:10802736], and this adhesion is tuned by polysialylation at N-glycan sites 5 and 6 (catalyzed by ST8SIA2 and ST8SIA4), which generates steric/electrostatic repulsion sufficient to override both NCAM and cadherin-mediated adhesion [PMID:15504723, PMID:17986444], and by ectodomain shedding via ADAM metalloproteases that down-regulates neuronal connectivity [PMID:16967505]. Transmembrane NCAM140, upon lipid-raft recruitment via palmitoylation, activates a signaling cascade involving RPTPα-dependent p59Fyn activation, spectrin-bridged PKCβ2, CaMKIIα-mediated RPTPα phosphorylation, and FGFR co-signaling, converging on FAK/Pyk2, Ras–MEK–ERK, PI3K–Akt, and CREB to drive neurite outgrowth, synapse remodeling, and—in NK cells—lytic granule exocytosis and cytotoxicity [PMID:11980923, PMID:15623578, PMID:18809727, PMID:32510326]. NCAM1 exon 18 alternative splicing is coupled to neuronal activity and differentiation state through intragenic histone modifications (H3K9ac, H3K9me2, H3K27me3) that alter RNA Pol II elongation kinetics [PMID:19251664, PMID:23892457].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"The observation that GPI-linked NCAM promoted myoblast fusion established that NCAM is not merely adhesive but functionally instructive for cell–cell merger during differentiation.\",\n      \"evidence\": \"Stable transfection of 125 kDa GPI-linked NCAM into myoblasts with quantitative fusion assay\",\n      \"pmids\": [\"2179732\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single isoform tested in one cell type\", \"mechanism linking GPI-NCAM to fusion machinery unknown\", \"not replicated with loss-of-function\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Functional mapping of the hinge region C-terminal to Ig5 revealed a PSA-masked domain essential for axon fasciculation and pathfinding, linking NCAM domain architecture to its in vivo guidance role.\",\n      \"evidence\": \"Monoclonal antibody perturbation and peptide epitope mapping in retina organ culture\",\n      \"pmids\": [\"8462735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"molecular partners of the hinge region not identified\", \"single antibody perturbation\", \"in vivo validation not performed\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"The finding that transmembrane NCAM-B but not GPI-linked NCAM-C downregulated MMP-9 and MMP-1 secretion established isoform-specific non-adhesive signaling functions for NCAM.\",\n      \"evidence\": \"Isoform transfection into NCAM-negative glioma cells; metalloproteinase activity assays\",\n      \"pmids\": [\"8265575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"mechanism of MMP transcriptional/secretory regulation not defined\", \"single cell line\", \"not independently replicated\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"The VASE insert in Ig domain 4 was shown to specifically inhibit NCAM-induced neurite outgrowth—potentially by blocking FGFR binding—revealing that alternative splicing encodes a functional switch in NCAM signaling capacity.\",\n      \"evidence\": \"PC12 cell transfection with NCAM ± VASE; synthetic VASE peptide inhibition; selectivity controls against other adhesion molecules\",\n      \"pmids\": [\"8163558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct VASE–FGFR interaction not demonstrated biochemically\", \"single lab\", \"in vivo significance of VASE not tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"In vitro reconstitution showed that polysialyltransferase PST-1 acts on terminal sialylation of NCAM N-glycan cores, establishing the enzymatic basis for PSA addition.\",\n      \"evidence\": \"Recombinant enzyme with NCAM glycosylation mutants in vitro\",\n      \"pmids\": [\"8805371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"site specificity within NCAM not resolved\", \"in vivo contribution of PST-1 vs other enzymes not yet distinguished\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"NCAM-null mice exhibited severe mossy fiber fasciculation and pathfinding defects that worsened with age, establishing NCAM as essential for axonal guidance and maintenance of neural circuitry in vivo.\",\n      \"evidence\": \"NCAM gene-targeted knockout mouse; histological analysis of hippocampal mossy fiber tract\",\n      \"pmids\": [\"9073395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"contributions of individual isoforms not resolved\", \"signaling pathway responsible for phenotype not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that NCAM140 clustering activates FAK, Fyn, Ras–MEK–ERK, and CREB phosphorylation identified the core intracellular signaling cascade downstream of NCAM-mediated adhesion.\",\n      \"evidence\": \"NCAM clustering assay in neural cells; pharmacological MAPK inhibition; phosphorylation assays in cerebellar neurons\",\n      \"pmids\": [\"10084688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct physical link between NCAM and Fyn not identified\", \"contribution of FGFR not yet delineated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Solving the crystal structure of the two N-terminal Ig domains revealed a cross-shaped antiparallel dimer, providing the atomic basis for homophilic trans-adhesion.\",\n      \"evidence\": \"X-ray crystallography at 1.85 Å resolution\",\n      \"pmids\": [\"10802736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structure of full ectodomain and role of FN3 domains in adhesion not resolved\", \"no structure of PSA-modified form\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Analysis of multiple NCAM/PSA-mutant mouse lines dissected PSA-dependent (circadian rhythmicity) from NCAM-dependent (entrainment) functions, revealing that PSA carried by NCAM is independently required for circadian clock regulation.\",\n      \"evidence\": \"Three NCAM/PSA transgenic mutant mouse strains; locomotor activity monitoring under LD and DD\",\n      \"pmids\": [\"11399310\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"molecular mechanism in SCN neurons not defined\", \"PSA's cellular targets in circadian circuit unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that NCAM140-induced neurite outgrowth requires both palmitoylation-dependent lipid raft localization and FGFR co-signaling established that NCAM signals through a dual-requirement platform integrating raft-associated kinases and a growth factor receptor.\",\n      \"evidence\": \"NCAM isoform transfection into NCAM-deficient hippocampal neurons; palmitoylation-site mutagenesis; lipid raft disruption; FGFR inhibitor\",\n      \"pmids\": [\"11980923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"physical NCAM–FGFR interaction not directly demonstrated\", \"identity of the palmitoyl transferase unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of the spectrin–PKCβ2 scaffold bridging NCAM to lipid rafts revealed that a cytoskeletal adaptor complex is required for signal transduction downstream of NCAM clustering.\",\n      \"evidence\": \"Co-immunoprecipitation; dominant-negative βI spectrin; lipid raft fractionation; neurite outgrowth in hippocampal neurons and CHO cells\",\n      \"pmids\": [\"12743109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"regulation of spectrin–NCAM stoichiometry not addressed\", \"PKCβ2 substrates in the pathway not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Biophysical force measurements established that polysialylation generates intermembrane repulsion sufficient to override both NCAM and cadherin adhesion, quantitatively explaining how PSA tunes cell–cell interactions.\",\n      \"evidence\": \"Molecular force measurements on membrane-bound NCAM with controlled PSA levels\",\n      \"pmids\": [\"15504723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"in vivo force magnitudes not measured\", \"effect of PSA chain length heterogeneity on repulsion not fully characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"RPTPα was identified as the molecular intermediary between NCAM140 and p59Fyn, resolving how NCAM adhesion is transduced into Src-family kinase activation; RPTPα knockout abolished NCAM-dependent neurite outgrowth.\",\n      \"evidence\": \"Co-immunoprecipitation; RPTPα-deficient mouse neurons; dominant-negative RPTPα; neurite outgrowth\",\n      \"pmids\": [\"15623578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RPTPα substrates beyond Fyn not characterized\", \"structural basis of NCAM–RPTPα interaction unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that ADAM-mediated NCAM ectodomain shedding, regulated by ERK, down-regulates neurite branching and connectivity—confirmed by a transgenic shedding mouse—established proteolytic shedding as a negative-feedback mechanism for NCAM function.\",\n      \"evidence\": \"Metalloprotease inhibition; transgenic NCAM-shedding mouse; cortical neuron neurite assays\",\n      \"pmids\": [\"16967505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"specific ADAM family member responsible not identified\", \"fate and signaling capacity of shed ectodomain not characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"GAP-43 was shown to potentiate NCAM-induced neurite outgrowth through NCAM180/spectrin interaction, while its absence shifts signaling to the NCAM140/Fyn pathway, revealing isoform-selective signaling modularity.\",\n      \"evidence\": \"Overexpression and dominant-negative constructs in PC12E2 cells and hippocampal neurons; kinase inhibitors; neurite outgrowth\",\n      \"pmids\": [\"17212696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"structural basis of GAP-43–spectrin–NCAM180 complex not resolved\", \"in vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Neuronal depolarization was shown to induce NCAM exon 18 skipping through intragenic H3K9 hyperacetylation that alters RNA Pol II elongation rate, establishing a chromatin-based mechanism coupling neuronal activity to NCAM alternative splicing.\",\n      \"evidence\": \"ChIP for H3K9ac and H3K36me3; slow Pol II mutant; HDAC inhibitor; RT-PCR in neurons\",\n      \"pmids\": [\"19251664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"chromatin remodeler responsible for intragenic H3K9ac not identified\", \"generality to other activity-regulated exons unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mass spectrometric analysis of PSA-NCAM from polysialyltransferase-knockout mice pinpointed N-glycosylation sites 5 and 6 as PSA acceptors and revealed synergistic action of ST8SiaII and ST8SiaIV controlling chain length.\",\n      \"evidence\": \"ST8SiaII- and ST8SiaIV-deficient mouse brains; glycopeptide mass spectrometry\",\n      \"pmids\": [\"17986444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"regulation of polysialyltransferase activity in vivo not elucidated\", \"functional consequence of PSA chain length differences not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The discovery that NCAM clustering activates voltage-dependent Ca²⁺ channels, leading to CaMKIIα phosphorylation of RPTPα at Ser180/Ser204 to enhance its phosphatase activity, closed the loop from adhesion event to kinase activation through a calcium-dependent amplification step.\",\n      \"evidence\": \"NCAM clustering; calcium imaging; co-immunoprecipitation; RPTPα site-directed mutagenesis; neurite outgrowth\",\n      \"pmids\": [\"18809727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"specific voltage-dependent Ca²⁺ channel subtypes not identified\", \"downstream RPTPα substrates beyond Fyn not characterized\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Systematic pharmacological dissection positioned FGFR, Src-family kinases, and G0/Gi proteins upstream of ERK, and cGMP/PI3K upstream of Akt in the NCAM signaling hierarchy, refining the branching logic of the pathway.\",\n      \"evidence\": \"Panel of pharmacological inhibitors in rat cerebellar granule neurons stimulated with NCAM ligand C3d\",\n      \"pmids\": [\"18656513\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single peptide ligand used\", \"genetic validation of individual pathway nodes not performed\", \"single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that NCAM–FGFR interaction drives ovarian cancer cell migration and metastatic dissemination—blockable by a targeted antibody—extended NCAM's functional role from neural development to cancer cell invasion.\",\n      \"evidence\": \"In vitro migration/invasion; mouse metastasis model; FGFR inhibition; anti-NCAM/FGFR antibody\",\n      \"pmids\": [\"21739604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular mechanism of NCAM–FGFR physical interaction not structurally defined\", \"applicability to other NCAM-expressing cancers not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Repressive intragenic marks H3K9me2 and H3K27me3 were shown to slow Pol II elongation and promote NCAM exon 18 inclusion during differentiation; intronic siRNA was sufficient to recapitulate this, establishing bidirectional chromatin-splicing coupling at the NCAM locus.\",\n      \"evidence\": \"ChIP; BIX01294 and 5-azacytidine inhibitors; intronic siRNA; Pol II elongation analysis\",\n      \"pmids\": [\"23892457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"endogenous trigger for intronic RNA-directed chromatin modification not identified\", \"whether this represents a general cotranscriptional splicing mechanism beyond NCAM unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"GFRα1 was identified as a direct NCAM interactor that functionally opposes NCAM-mediated adhesion to promote Purkinje cell migration, establishing a ligand-receptor antagonism that tunes neuronal positioning during cerebellar development.\",\n      \"evidence\": \"GFRα1-KO and NCAM genetic reduction mice; double-mutant epistasis; migration assays\",\n      \"pmids\": [\"28076782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis of GFRα1–NCAM interaction not resolved\", \"downstream signaling mediating antagonism not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"TGFβ1-induced NCAM1 upregulation via p38 was shown to alter intercalated disc structure in cardiomyocytes, extending NCAM's adhesive role to cardiac tissue remodeling.\",\n      \"evidence\": \"Cardiac-specific TGFβ1 transgenic mice; NCAM1 knockdown rescue; p38 inhibition; electron microscopy\",\n      \"pmids\": [\"28870505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"NCAM binding partners at intercalated discs not identified\", \"relevance to human cardiomyopathy not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"NCAM1 turnover in anterior cingulate cortex synapses after peripheral nerve injury was linked to spine reorganization and behavioral pain sensitization, connecting NCAM1 to synaptic plasticity in neuropathic pain.\",\n      \"evidence\": \"Nerve injury mouse model; synaptic protein turnover assay; ACC-specific NCAM1 manipulation; spine imaging; behavioral assay\",\n      \"pmids\": [\"29346771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"mechanism regulating NCAM1 turnover at synapses not defined\", \"causal signaling pathway not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic depletion of NCAM1 in AML cells induced apoptosis/differentiation and sensitized to chemotherapy through constitutive MAPK pathway dependency, identifying NCAM1 as a survival factor in leukemia.\",\n      \"evidence\": \"NCAM1 knockdown/knockout in AML cell lines; murine leukemia serial transplantation; phosphoproteomics; MEK1/2 inhibition\",\n      \"pmids\": [\"30814062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism of constitutive MAPK activation by NCAM1 in AML not fully defined\", \"patient stratification by NCAM1 expression not validated clinically\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NCAM1 was identified as a Zika virus entry receptor, with overexpression increasing and knockout decreasing infection, revealing an unexpected role in viral pathogenesis.\",\n      \"evidence\": \"Chemical proteomics with photocrosslinking probe; NCAM1 overexpression and KO in Vero and U-251 MG cells\",\n      \"pmids\": [\"32753727\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"ZIKV envelope–NCAM1 binding site not structurally characterized\", \"contribution relative to other entry factors (e.g., AXL) not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR knockout and rescue of CD56 in NK cells demonstrated that NCAM1 promotes lytic granule exocytosis and cytotoxicity through Pyk2 Tyr402 phosphorylation, establishing a non-neuronal signaling function for NCAM1 in innate immunity.\",\n      \"evidence\": \"CRISPR/Cas9 KO in NK92; CD56 reintroduction rescue; granule exocytosis assay; Pyk2 phosphorylation\",\n      \"pmids\": [\"32510326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism linking NCAM1 to Pyk2 activation not molecularly defined\", \"whether RPTPα/Fyn pathway operates in NK cells not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Patient-derived anti-NCAM1 autoantibodies disrupted homophilic adhesion and Fyn–FAK–MEK–ERK signaling, reduced dendritic spines, and induced schizophrenia-like behaviors in mice, establishing a pathogenic mechanism linking NCAM1 disruption to psychiatric disease.\",\n      \"evidence\": \"Autoantibody characterization by cell-based assay/ELISA; intracerebroventricular injection in mice; spine imaging; behavioral testing; phosphoprotein analysis\",\n      \"pmids\": [\"35492247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"prevalence of anti-NCAM1 autoantibodies in schizophrenia populations not established\", \"whether antibodies target specific NCAM1 domains not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"KLK8 was identified as a protease that cleaves the NCAM1 ectodomain in hippocampus under chronic stress, causing neuronal apoptosis rescuable by NCAM1 overexpression, linking NCAM1 proteolysis to stress-induced neurodegeneration.\",\n      \"evidence\": \"KLK8 transgenic and knockout mice; co-IP; NCAM1 overexpression rescue; apoptosis assays in HT22 cells and primary neurons\",\n      \"pmids\": [\"37076499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab\", \"KLK8 cleavage site on NCAM1 not mapped\", \"in vivo rescue of stress phenotype by NCAM1 not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the full-length ectodomain structure with PSA modification, the molecular basis of the NCAM–FGFR physical interaction, how NCAM1 activates Pyk2 in NK cells, and whether chromatin-based splicing regulation at the NCAM locus generalizes to other activity-dependent exons.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"no structure of PSA-modified full ectodomain\", \"NCAM–FGFR binding interface not resolved\", \"Pyk2 activation mechanism in NK cells unknown\", \"generality of intragenic chromatin-splicing coupling unclear\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 1, 14, 21]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 4, 7, 20]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 3, 5, 6, 7, 13, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [3, 4, 6, 7, 18, 27]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 1, 14, 21, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [13, 14, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 10, 25]}\n    ],\n    \"complexes\": [\n      \"NCAM-spectrin-PKCβ2\",\n      \"NCAM-RPTPα-CaMKIIα\"\n    ],\n    \"partners\": [\n      \"PTPRA\",\n      \"FYN\",\n      \"GAP43\",\n      \"SPTBN1\",\n      \"GFRA1\",\n      \"FGFR1\",\n      \"KLK8\",\n      \"PYK2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NCAM1 is a multifunctional immunoglobulin-superfamily cell adhesion molecule that mediates homophilic and heterophilic cell–cell interactions critical for neural development, synaptic plasticity, and immune cell cytotoxicity. Its extracellular region contains five Ig-like domains that form cis-dimers and zipper-like trans-interactions, with adhesion strength negatively regulated by polysialylation (catalyzed by ST8SIA2 and ST8SIA4) through steric and ionic repulsion [PMID:10802736, PMID:15504723, PMID:17986444]. The NCAM140 isoform, whose lipid-raft association depends on palmitoylation, recruits RPTPα to activate Fyn and FAK, triggering Ras→MEK→ERK1/2 and CREB phosphorylation to drive neurite outgrowth; NCAM additionally signals through direct binding to FGFR1 via its fibronectin type III modules and serves as a RET-independent GDNF co-receptor via GFRα1, activating Fyn/FAK in Schwann cells and neurons [PMID:9079653, PMID:10084688, PMID:12791257, PMID:12837245, PMID:11980923]. Beyond the nervous system, NCAM1 promotes NK-cell lytic granule exocytosis through Pyk2 signaling and sustains leukemic stem cell survival in AML via constitutive MAPK activation [PMID:32510326, PMID:30814062].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Molecular cloning resolved NCAM's domain architecture—five Ig-like extracellular domains shared by three major isoforms (120, 140, 180 kDa)—and established that homophilic binding resides in the Ig domains while isoform diversity arises from alternative splicing of cytoplasmic segments, providing the structural framework for all subsequent signaling studies.\",\n      \"evidence\": \"cDNA cloning and amino acid sequencing of CNBr/proteolytic fragments, Northern blot; additional tissue-specific (muscle MSD1) and secreted isoforms identified by cDNA cloning\",\n      \"pmids\": [\"3576199\", \"2887295\", \"3203385\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional structure of the full extracellular domain was not yet determined\", \"Cytoplasmic signaling partners unknown\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Functional experiments demonstrated that polysialic acid (PSA) on NCAM generates steric exclusion that inhibits membrane apposition and cell–cell contact, establishing PSA as a negative regulator of NCAM-mediated adhesion rather than a binding enhancer.\",\n      \"evidence\": \"Cell adhesion assays with enzymatic PSA removal and antibody blocking\",\n      \"pmids\": [\"3281256\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of polysialyltransferase(s) unknown\", \"Quantitative biophysical characterization of repulsion pending\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Discovery that NCAM's fourth Ig domain binds L1 glycans in cis via a lectin-like motif, and that transmembrane NCAM isoforms regulate MMP secretion, expanded NCAM's role beyond simple adhesion to heterophilic cis-signaling and extracellular matrix remodeling.\",\n      \"evidence\": \"Co-IP, recombinant domain binding, peptide inhibition of L1–NCAM, neurite outgrowth assay; transfection of glioma cells with isoform-specific constructs and MMP zymography\",\n      \"pmids\": [\"8509458\", \"8265575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of L1–NCAM cis-complex unresolved\", \"Downstream effectors linking NCAM to MMP gene regulation unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Cloning of polysialyltransferases PST-1 and ST8SIA2 and reconstitution of PSA synthesis on NCAM in vitro identified the enzymes responsible for NCAM polysialylation, enabling subsequent genetic dissection of PSA function.\",\n      \"evidence\": \"Expression cloning, in vitro enzymatic reconstitution with defined NCAM substrates, stable transfection in NCAM-expressing cell lines\",\n      \"pmids\": [\"7854457\", \"8805371\", \"7624364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of the two polysialyltransferases in vivo not yet resolved\", \"Chain-length control mechanism unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of p59fyn and p125FAK as isoform-selective (NCAM140-specific) signaling effectors, together with the demonstration that NCAM-knockout mice have severe mossy fiber pathfinding defects, connected NCAM to intracellular kinase cascades and established its in vivo requirement for axon guidance.\",\n      \"evidence\": \"Co-IP from neonatal brain and transfected cells, tyrosine phosphorylation assays; NCAM-knockout mouse histology and tract tracing\",\n      \"pmids\": [\"9079653\", \"9073395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking Fyn/FAK to cytoskeletal remodeling unknown\", \"How NCAM140 selectively recruits Fyn (not NCAM180 or 120) unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Full Ras→MEK→ERK1/2→CREB pathway downstream of NCAM140 was mapped, and MEK inhibition selectively blocked NCAM-driven neurite outgrowth, establishing MAPK as the principal effector cascade for NCAM-dependent neuritogenesis.\",\n      \"evidence\": \"NCAM antibody clustering, specific MEK/Ras inhibitors, phospho-kinase assays, cerebellar neuron neurite outgrowth\",\n      \"pmids\": [\"10084688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Parallel PI3K/Akt and cGMP branches not yet placed in signaling hierarchy\", \"Nuclear transcriptional targets of CREB downstream of NCAM undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Crystal structure of the two N-terminal Ig domains revealed antiparallel cis-dimers that assemble into zipper-like trans-arrays, providing the first atomic model of homophilic NCAM recognition; concurrently, PSA-NCAM was shown to bind BDNF and modulate hippocampal LTP via TrkB.\",\n      \"evidence\": \"X-ray crystallography at 1.85 Å; NCAM-KO and Endo-N-treated hippocampal slices with BDNF rescue and TrkB phosphorylation\",\n      \"pmids\": [\"10802736\", \"10760298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of full-length extracellular region (all five Ig + FNIII domains) not determined\", \"Direct PSA–BDNF binding site unmapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Two parallel signaling axes were delineated: palmitoylation-dependent lipid-raft localization of NCAM140 was shown essential for Fyn/FAK/ERK activation, and NCAM was identified as a RET-independent co-receptor for GDNF via GFRα1, activating Fyn/FAK in RET-null cells to promote Schwann cell migration and axon growth.\",\n      \"evidence\": \"Palmitoylation-site mutagenesis, raft disruption (MβCD), FGFR inhibitor in NCAM-null hippocampal neurons; co-IP and kinase assays in RET-deficient cells, migration and neurite outgrowth assays\",\n      \"pmids\": [\"11980923\", \"12837245\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GDNF–NCAM and FGFR–NCAM pathways converge or remain independent unclear\", \"Palmitoylation enzyme(s) for NCAM not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"NMR and SPR experiments mapped the direct NCAM–FGFR1 binding interface to NCAM FNIII modules 1–2 and FGFR1 Ig2–3, and revealed that extracellular ATP competes for the same NCAM surface, acting as a molecular switch that inhibits NCAM–FGFR signaling and neurite outgrowth.\",\n      \"evidence\": \"NMR structure of NCAM F3 module 2, surface plasmon resonance, FGFR phosphorylation and neurite outgrowth assays\",\n      \"pmids\": [\"12791257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological regulation of local ATP concentration at the NCAM–FGFR interface unknown\", \"Whether ATP regulation applies to all NCAM-expressing cell types untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"NCAM signals through a spectrin–PKCβ2 scaffold that is redistributed to lipid rafts in an FGFR-dependent manner; disrupting this scaffold with dominant-negative βI spectrin blocked neurite outgrowth, linking cytoskeletal adaptor assembly to NCAM function.\",\n      \"evidence\": \"Co-IP, lipid raft fractionation, dominant-negative βI spectrin transfection, FGFR inhibitor, neurite outgrowth assay in hippocampal neurons\",\n      \"pmids\": [\"12743109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How spectrin crosslinking mechanically couples to growth cone advance not defined\", \"Structural basis of NCAM180–spectrin interaction unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantitative biophysical force measurements showed that PSA overwhelms both NCAM homophilic and cadherin-mediated attraction at physiological ionic strength, while RPTPα was identified as the direct bridge linking NCAM140 to Fyn activation, with RPTPα-knockout neurons losing NCAM-dependent signaling.\",\n      \"evidence\": \"Surface force apparatus on reconstituted membranes; RPTPα-KO neurons, dominant-negative RPTPα, co-IP, lipid raft fractionation, neurite outgrowth\",\n      \"pmids\": [\"15504723\", \"15623578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of NCAM–RPTPα complex not determined\", \"Whether PSA removal fully restores adhesive strength in vivo unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"In vivo analysis of ST8SiaII and ST8SiaIV knockout mice resolved their relative contributions: both enzymes modify NCAM glycosylation sites 5 and 6, but synergize to produce long polySia chains, with ST8SiaIV as the dominant modifier.\",\n      \"evidence\": \"Polysialyltransferase-KO mice, glycopeptide mass spectrometry, polySia chain-length analysis\",\n      \"pmids\": [\"17986444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of site-specific polysialyltransferase recruitment unresolved\", \"Chain-length termination mechanism unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A Ca²⁺-dependent signaling branch was uncovered: NCAM clustering opens T/L-type Ca²⁺ channels, activating CaMKIIα, which phosphorylates RPTPα at Ser180/204 to boost its phosphatase activity, establishing a parallel Ca²⁺→CaMKII→RPTPα→Fyn cascade for neurite outgrowth.\",\n      \"evidence\": \"NCAM clustering, Ca²⁺ channel co-IP, CaMKIIα activation, RPTPα serine-phosphorylation mutants, neurite outgrowth in hippocampal neurons\",\n      \"pmids\": [\"18809727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of T/L-type channel subunits complexed with NCAM not defined\", \"How this Ca²⁺ branch integrates with Ras–MAPK signaling quantitatively unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Activity-dependent alternative splicing of NCAM exon 18 was shown to be governed by intragenic epigenetic changes: membrane depolarization induces H3K9 hyperacetylation at the exon 18 locus, altering RNA Pol II elongation rate and exon inclusion, establishing a novel chromatin-based splicing switch.\",\n      \"evidence\": \"Neuronal depolarization, RT-PCR splicing, slow Pol II mutant, ChIP for H3K9ac/H3K36me3, HDAC inhibitor TSA; later confirmed by intragenic repressive marks (H3K9me2, H3K27me3) and intronic siRNA-directed chromatin remodeling during differentiation\",\n      \"pmids\": [\"19251664\", \"23892457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin reader and splicing factor that interpret the marks not identified\", \"Whether this mechanism operates in non-neuronal NCAM-expressing cells unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"ADAM metalloprotease-mediated ectodomain shedding of NCAM140, regulated by ERK1/2, was identified as a physiological modulator of neurite outgrowth and connectivity, with a transgenic shedding model showing impaired neuronal connectivity.\",\n      \"evidence\": \"Pharmacological inhibitors, metalloprotease inhibitors, transgenic NCAM-shedding mouse, neurite outgrowth assay\",\n      \"pmids\": [\"16967505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ADAM family member(s) responsible not identified\", \"Whether shed NCAM acts as a soluble ligand or simply removes receptor unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"In AML, NCAM1 was found to sustain leukemia-initiating cell survival via constitutive MAPK activation; genetic depletion induced differentiation or death and sensitized blasts to chemotherapy, repositioning NCAM1 as a therapeutic target outside the nervous system.\",\n      \"evidence\": \"Genetic knockdown/KO, phosphoproteomics, transcriptomics, murine transplantation leukemia model, MEK1/2 inhibitor sensitization\",\n      \"pmids\": [\"30814062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of constitutive MAPK activation by NCAM1 in AML (ligand-independent?) unclear\", \"Whether anti-NCAM1 therapy is effective without chemotherapy combination unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two non-neural roles were established: NCAM1 was identified as a Zika virus entry receptor by chemical proteomics, and CRISPR knockout in NK cells demonstrated that NCAM1 drives lytic granule exocytosis and immunological synapse polarization via Pyk2 Tyr402 phosphorylation.\",\n      \"evidence\": \"Photocrosslinking chemical proteomics, NCAM1 overexpression/KO infection assays (Zika); CRISPR-Cas9 KO in NK92 cells with CD56 rescue, phospho-Pyk2 immunoblot, granule exocytosis and synapse assays\",\n      \"pmids\": [\"32753727\", \"32510326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ZIKV binding site on NCAM1 extracellular domain not mapped\", \"Whether Pyk2 binds NCAM1 directly or via an adaptor unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Patient-derived anti-NCAM1 autoantibodies disrupted homophilic binding, GDNF interaction, and Fyn signaling, and when introduced intrathecally in mice, reduced FAK/MEK/ERK phosphorylation, spine/synapse density, and caused schizophrenia-related behaviors, providing causal evidence linking NCAM1 signaling disruption to psychiatric disease.\",\n      \"evidence\": \"Patient autoantibody characterization, in vitro interaction blocking, intracerebrospinal injection in mice, spine/synapse immunofluorescence, pre-pulse inhibition and cognitive behavioral assays\",\n      \"pmids\": [\"35492247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Epitope specificity of pathogenic autoantibodies not mapped at residue level\", \"Whether anti-NCAM1 autoantibodies are causative or secondary in schizophrenia patients unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"KLK8 serine protease was identified as a novel extracellular protease that cleaves NCAM1, reducing surface expression in hippocampal neurons; NCAM1 overexpression or a mimetic peptide rescued KLK8-driven neuronal apoptosis and depression-like behavior.\",\n      \"evidence\": \"KLK8 transgenic/KO mice, CUMS model, protease cleavage assay, co-IP, adenoviral NCAM1 overexpression and mimetic peptide rescue\",\n      \"pmids\": [\"37076499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"KLK8 cleavage site on NCAM1 not determined\", \"Whether KLK8-mediated NCAM1 shedding generates a bioactive soluble fragment unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full-length extracellular domain structure in a membrane context, how NCAM1's multiple signaling arms (FGFR, GFRα1/GDNF, RPTPα/Fyn, Ca²⁺/CaMKII, Pyk2) are integrated spatiotemporally, the identity and regulation of palmitoylation enzymes for NCAM, the structural basis of the NCAM1–Pyk2 connection in NK cells, and whether NCAM1 can be therapeutically targeted in AML or as a viral entry receptor without neurological consequences.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length ectodomain structure in lipid bilayer context\", \"Quantitative model integrating parallel signaling cascades lacking\", \"Therapeutic window for NCAM1 targeting in cancer/infection versus neural side effects undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 3, 14, 19]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [11, 13, 15, 16]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [15, 30]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 14, 16, 20, 35]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 13, 15, 16, 18, 20, 23, 25, 33, 35]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 3, 14, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 7, 12, 30]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [12, 13, 32, 38]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [35]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [27, 33, 34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FGFR1\",\n      \"PTPRA\",\n      \"FYN\",\n      \"PTK2\",\n      \"GFRA1\",\n      \"SPTBN1\",\n      \"PTK2B\",\n      \"L1CAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}